|
For the year ended November 30, 2014
|
|
Commission File Number 1-15147
|
Ohio
|
|
34-1897652
|
(State of Incorporation)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
25435 Harvard Road, Beachwood, Ohio
|
|
44122-6201
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Title of each
class
|
|
Name of each exchange
on which registered
|
Common Stock, par value 10¢ per share
|
|
The New York Stock Exchange
|
Large accelerated filer
¨
|
|
Accelerated filer
þ
|
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
|
|
|
|
(do not check if a smaller reporting company)
|
|
|
|
Item
Number
|
|
|
|
|
|
|
|
PART I
|
|
|
|
1
|
|
||
1A
|
|
||
1B
|
|
||
2
|
|
||
3
|
|
||
4
|
|
||
4A
|
|
||
|
|
|
|
PART II
|
|
|
|
5
|
|
||
6
|
|
||
7
|
|
||
7A
|
|
||
8
|
|
||
9
|
|
||
9A
|
|
||
9B
|
|
||
|
|
|
|
PART III
|
|
|
|
10
|
|
||
11
|
|
||
12
|
|
||
13
|
|
||
14
|
|
||
|
|
|
|
PART IV
|
|
|
|
15
|
|
||
|
|
Item 1.
|
|
Business
|
Product Line
|
|
% of Performance
Chemicals Fiscal
2014 Net Sales
|
|
Primary Products
|
|
End-use Applications
|
|
Brand Names
|
Performance Materials
|
|
42%
|
|
SB and SBA latex
binders and
crosslinkers,
lubricants and
hollow plastic
pigments, styrene butadiene vinyl pyridine, VP latex and bio-based polymers
|
|
Paper, Packaging, Carpet and Tire Cord
|
|
SUNREZ, OMNAREZ, SUNKOTE, SEQUALFLOW, SUNKEM, GENCRYL, SUNSIZE, ECOKOTE, ACCUKOTE, LYTRON, HPP, REACTOPAQUE, GENFLO, GENCRYL PT, OMNAGLIDE, SEQUAREZ, GENTAC, PLIOCORD, OMNATUF, OMNABLOC, GENCAL, NOVAGREEN, LYTRON
|
Product Line
|
|
% of Performance
Chemicals Fiscal
2014 Net Sales
|
|
Primary Products
|
|
End-use Applications
|
|
Brand Names
|
Specialty Chemicals
|
|
58%
|
|
SB, SBA, acrylic,
vinyl acrylic, styrene
acrylic and polyvinyl
acetate emulsion
polymers, solid
plastic pigments,
solid & glyoxal
resins, phenolic and
diphenylamine
antioxidants, NBR
powders and
dispersions,
elastomers, silicone
emulsions,
polyethylene resins, and fluoropolymers, opacifiers and bio-based polymers
|
|
Nonwovens, Textiles, Graphic Arts, In-mold Coatings, Floor Care, Oil & Gas, Coatings, Construction, Fluorosurfactants, Antioxidants, EMOD, Reinforcing Resins and Opacifier/Personal Care
|
|
PERMALOFT, OMNABOND, SUNSIZE, GENFLO, GENCRYL, OMNAPEL, SEQUABOND, SUNCRYL, ACRYGEN, SUNBOND, SEDGERES, PRYM, SEDGEQUEST, SEDGELEV, SEDGESPERSE, SEDGESAV, SEQUAWET, SEQUACLEAN, WARCOSET, WARCO, SEQUASOFT, SEDGELCLEAN, SEDGEDYE, SEDGEFIX, SEDGEGARD, SEDGEKIL, SEDGELUB, SEDGEMUL, SEQUALINK, SEDGESCOUR, SEDGESOFT, SUNKOTE, MYKON, PERMAFRESH, SEQUAPEL, X-CAPE, MYKOSOFT, MYKOSIL, NORANE, IMPREGNOLE, MYKOWICK, ACRYGEN, NOVACRYL, GENFLO, SECOAT, SECRYL, SEQUABOND, CDP, UNIQ-PRINT, GENGLAZE, STYLECOAT, OMNAGLO, MORGLO, RWL, ML, MORFLO, MORSHINE, CONREZ, NM, NH, CONLEX, VERUS, VISCODRILL, GENCEAL, CM, DF, HYDROPLIOLITE, PLIOLITE, PLIOTONE, PLIOWAY, PLIOTEC, GENCEAL, POLYFOX, WINGSTAY, SUNIGUM, CHEMIGUM, LYTRON
|
Product Line
|
|
% of Engineered Surfaces Fiscal
2014 Net Sales |
|
Primary Products
|
|
End-use Applications
|
|
Brand Names
|
Coated Fabrics
|
|
41%
|
|
Vinyl and urethane coated fabrics
|
|
Seating surfacing for transportation, marine, offices, hotels, hospital and health care facilities, stores, schools, restaurants, public buildings, and residences; and industrial applications
|
|
BOLTAFLEX, BOLTASOFT, HEALTHGAURD, NAUTOLEX, PREFIXX, PREVAILL, PINNACLE
|
Laminates and Performance Films
|
|
59%
|
|
Vinyl, paper, and specialty laminates; performance films
|
|
Decorative and protective surfacing for kitchen and bath cabinets, manufactured housing, recreational vehicle interiors, flooring, commercial and residential furniture, retail display and food service fixtures, home furnishings and consumer appliances, wall panel systems, decorative wall surfacing; industrial films for banners, tents, ceiling tiles, decking, health care furniture, and bath and spa surrounds
|
|
RADIANCE,
SURF(X), DESIGN4, EFX, DURAMAX, HARMONY, VIEWNIQUE
|
•
|
Coated Fabrics — Morbern, Beneke, Uniroyal, and Spradling International
|
•
|
Laminates and Performance Films — Wilsonart, Toppan Printing, Renolit Corporation, LG Chemical America, PolyOne Corporation, and I2M
|
Item 1A.
|
|
Risk Factors
|
•
|
fluctuations in currency exchange rates;
|
•
|
region to region fluctuations in key raw material costs;
|
•
|
transportation delays and interruptions;
|
•
|
political and economic instability and disruptions;
|
•
|
denial or revocation of, and delays in obtaining, governmental licenses and permits;
|
•
|
the imposition of duties and tariffs;
|
•
|
import and export controls;
|
•
|
government control of capital transactions, including the borrowing of funds for operations or the expatriation of cash;
|
•
|
difficulties in staffing and managing operations;
|
•
|
limitations on our ability to enforce legal rights and remedies;
|
•
|
more stringent environmental, health and safety laws and regulations;
|
•
|
potentially adverse tax consequences; and
|
•
|
government expropriation of a business or assets.
|
•
|
difficulty integrating operations and personnel at different locations;
|
•
|
diversion of management attention;
|
•
|
potential disruption of ongoing business because of the unknown reactions to the combination of OMNOVA and the acquisition by customers, suppliers and other key constituencies;
|
•
|
difficulties in assimilating the technologies and products of the acquisition;
|
•
|
inability to retain key personnel;
|
•
|
inability to successfully incorporate acquired business components with our existing operational and accounting infrastructure;
|
•
|
difficulty in expanding product manufacturing to new sites; and
|
•
|
inability to maintain uniform standards, controls, procedures and policies.
|
•
|
make it more difficult for us to satisfy our obligations with respect to the notes, the term loan and the revolving credit facility;
|
•
|
increase our vulnerability to general adverse economic and industry conditions, including interest rate fluctuations, because a portion of our borrowings, including those under the term loan and the revolving credit facility, are at variable rates of interest;
|
•
|
require us to dedicate a substantial portion of our cash flow from operations to payments on our debt, thereby reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions, joint ventures, pension contributions and investments and other general corporate purposes;
|
•
|
limit our flexibility in planning for, or reacting to, changes in our business and the product categories in which we participate;
|
•
|
limit our ability to obtain additional debt or equity financing due to applicable financial and restrictive covenants in our debt agreements, and;
|
•
|
place us at a competitive disadvantage compared to our competitors that have less debt.
|
•
|
incur additional debt or issue certain disqualified stock and preferred stock;
|
•
|
pay dividends or certain other distributions on our capital stock or repurchase our capital stock;
|
•
|
make certain investments or other restricted payments;
|
•
|
place restrictions on the ability of our restricted subsidiaries to pay dividends or make other payments to us;
|
•
|
engage in transactions with affiliates;
|
•
|
sell certain assets or merge with or into other companies;
|
•
|
enter into sale and leaseback transactions;
|
•
|
guarantee debt;
|
•
|
create liens; and
|
•
|
enter into unrelated businesses.
|
Item 1B.
|
|
Unresolved Staff Comments
|
Item 2.
|
|
Properties
|
*
|
|
An asterisk next to a facility listed above indicates that it is a leased property.
|
Item 3.
|
|
Legal Proceedings
|
Item 4.
|
|
Submission of Matters to a Vote of Security Holders
|
Item 4A.
|
|
Executive Officers of the Registrant
|
Item 5.
|
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
Item 6.
|
|
Selected Financial Data
(1)
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
||||||||||
|
(Dollars in millions, except per share data)
|
||||||||||||||||||
Statement of operations data:
|
|
|
|
|
|
|
|
|
|
||||||||||
Net Sales
|
$
|
987.4
|
|
|
$
|
1,018.1
|
|
|
$
|
1,125.5
|
|
|
$
|
1,201.1
|
|
|
$
|
781.7
|
|
Cost of goods sold (exclusive of depreciation)
(2)
|
788.0
|
|
|
805.4
|
|
|
898.3
|
|
|
982.5
|
|
|
635.3
|
|
|||||
Gross profit
|
199.4
|
|
|
212.7
|
|
|
227.2
|
|
|
218.6
|
|
|
146.4
|
|
|||||
Selling, general, and administrative
|
120.2
|
|
|
118.1
|
|
|
121.2
|
|
|
108.6
|
|
|
77.6
|
|
|||||
Depreciation and amortization
|
34.8
|
|
|
33.6
|
|
|
32.0
|
|
|
33.5
|
|
|
18.7
|
|
|||||
Fixed asset impairment
(3)
|
—
|
|
|
.2
|
|
|
1.0
|
|
|
3.1
|
|
|
2.7
|
|
|||||
Gain on asset sales
(4)
|
.5
|
|
|
(4.9
|
)
|
|
—
|
|
|
1.2
|
|
|
—
|
|
|||||
Restructuring and severance
(5)
|
.9
|
|
|
7.1
|
|
|
1.0
|
|
|
1.6
|
|
|
.5
|
|
|||||
Interest expense
(10)
|
32.9
|
|
|
31.9
|
|
|
36.5
|
|
|
38.0
|
|
|
8.7
|
|
|||||
Acquisition and integration related expense
(6)
|
—
|
|
|
—
|
|
|
—
|
|
|
2.3
|
|
|
5.5
|
|
|||||
Debt issuance costs write-off
|
.8
|
|
|
1.5
|
|
|
—
|
|
|
1.0
|
|
|
—
|
|
|||||
Other (income) expense, net
(2)(7)
|
(2.4
|
)
|
|
(1.3
|
)
|
|
(1.4
|
)
|
|
(.8
|
)
|
|
(.6
|
)
|
|||||
|
187.7
|
|
|
186.2
|
|
|
190.3
|
|
|
188.5
|
|
|
113.1
|
|
|||||
Income from continuing operations before income taxes
|
11.7
|
|
|
26.5
|
|
|
36.9
|
|
|
30.1
|
|
|
33.3
|
|
|||||
Income tax (benefit) expense
(8)
|
(.4
|
)
|
|
6.0
|
|
|
11.2
|
|
|
13.4
|
|
|
(83.9
|
)
|
|||||
Income from continuing operations
|
12.1
|
|
|
20.5
|
|
|
25.7
|
|
|
16.7
|
|
|
117.2
|
|
|||||
Discontinued Operations, net of tax:
|
|
|
|
|
|
|
|
|
|
||||||||||
(Loss) from operations
(9)
|
(.6
|
)
|
|
(.9
|
)
|
|
(4.1
|
)
|
|
(19.5
|
)
|
|
(9.3
|
)
|
|||||
Gain on sale
|
—
|
|
|
—
|
|
|
6.0
|
|
|
—
|
|
|
—
|
|
|||||
(Loss) income from discontinued operations
|
(.6
|
)
|
|
(.9
|
)
|
|
1.9
|
|
|
(19.5
|
)
|
|
(9.3
|
)
|
|||||
Net income (loss)
|
$
|
11.5
|
|
|
$
|
19.6
|
|
|
$
|
27.6
|
|
|
$
|
(2.8
|
)
|
|
$
|
107.9
|
|
Basic income (loss) per share:
|
|
|
|
|
|
|
|
|
|
||||||||||
Income from continuing operations
|
$
|
.26
|
|
|
$
|
.44
|
|
|
$
|
.56
|
|
|
$
|
.37
|
|
|
$
|
2.63
|
|
(Loss) Income from discontinued operations
|
(.01
|
)
|
|
(.02
|
)
|
|
.05
|
|
|
(.43
|
)
|
|
(.21
|
)
|
|||||
Net income (loss) per share
|
$
|
.25
|
|
|
$
|
.42
|
|
|
$
|
.61
|
|
|
$
|
(.06
|
)
|
|
$
|
2.42
|
|
Diluted income (loss) per share:
|
|
|
|
|
|
|
|
|
|
||||||||||
Income from continuing operations
|
$
|
.26
|
|
|
$
|
.44
|
|
|
$
|
.56
|
|
|
$
|
.37
|
|
|
$
|
2.61
|
|
(Loss) Income from discontinued operations
|
(.01
|
)
|
|
(.02
|
)
|
|
.04
|
|
|
(.43
|
)
|
|
(.21
|
)
|
|||||
Net income (loss) per share
|
$
|
.25
|
|
|
$
|
.42
|
|
|
$
|
.60
|
|
|
$
|
(.06
|
)
|
|
$
|
2.40
|
|
General:
|
|
|
|
|
|
|
|
|
|
||||||||||
Capital expenditures
|
$
|
29.8
|
|
|
$
|
28.9
|
|
|
$
|
32.8
|
|
|
$
|
24.1
|
|
|
$
|
13.7
|
|
Total assets
|
$
|
829.2
|
|
|
$
|
854.7
|
|
|
$
|
873.7
|
|
|
$
|
865.1
|
|
|
$
|
727.0
|
|
Long-term debt
(10)
|
$
|
409.2
|
|
|
$
|
447.0
|
|
|
$
|
442.6
|
|
|
$
|
444.3
|
|
|
$
|
389.4
|
|
Cash
(10)
|
$
|
99.5
|
|
|
$
|
164.9
|
|
|
$
|
148.5
|
|
|
$
|
103.1
|
|
|
$
|
324.3
|
|
(1)
|
During November 2011, the Company committed to a plan to dispose of substantially all of its Engineered Surfaces commercial wallcovering operations. As such, the results of operations for these businesses have been classified as discontinued operations for all periods presented.
|
(2)
|
During 2010, the Company recognized strike-related costs of $2.4 million of which $1.4 million is recorded in cost of goods sold and $1.0 million is recorded in other income (expense).
|
(3)
|
During 2013, the Company recognized intangible asset impairment charges of $0.2 million to write down the value of one of its trademarks to fair value. During 2012, the Company recognized asset impairment charges of $1.0 million to write down the value of its Columbus, Mississippi facility and to write off other assets no longer used (see Management's Discussion and Analysis of Financial Condition and Results of Operations - Discontinued Operations). During 2011, the Company recognized asset impairment charges of $3.1 million due to the idling of a plant in Taicang, China and the planned realignment of coated fabrics production amongst existing facilities. During 2010, the Company recorded asset impairment charges of $2.7 million to write down machinery and equipment at its Columbus, Mississippi plant to fair value.
|
(4)
|
During 2013, gain on asset sales primarily relates to the sale of equipment and plants in Columbus, Mississippi and Taicang, China.
|
(5)
|
Restructuring and severance consisted primarily of severance costs of $0.9 million in 2014 and facility closure costs of $2.6 million and severance costs of $4.5 million in 2013, $1.0 million in 2012, $1.6 million in 2011, and $0.5 million in 2010.
|
(6)
|
The Company recognized acquisition and integration costs of $2.3 million and $5.5 million in 2011 and 2010, respectively, related to the purchase of ELIOKEM International SAS, which was acquired on December 9, 2010.
|
(7)
|
During 2010, the Company recorded a charge of $9.2 million for a fair value adjustment on a foreign currency collar and recorded a gain of $9.7 million from the dissolution of a joint venture marketing alliance.
|
(8)
|
During 2014, the Company reversed a valuation allowance of $6.9 million related to capital loss carryforwards in the U.S. During 2010, the Company reversed a significant portion of its deferred tax valuation allowance of $98.2 million.
|
(9)
|
Includes long-lived asset impairment charges of $13.6 million and $3.5 million in 2011 and 2010, respectively.
|
(10)
|
Included in 2014 and 2013 is $17.6 million and $3.0 million, respectively, for capital leases. During 2014, the Company prepaid $50.0 million of its Senior Notes for which it incurred $2.0 million in premium fees which is included in interest expense and wrote-off $0.8 million of related deferred financing fees. During 2010, in connection with the pending acquisition of Eliokem International SAS, the Company issued $250 million of Senior Notes, the proceeds of which were held in escrow and included in cash as of November 30, 2010, and subsequently used on December 9, 2010 to fund the acquisition.
|
Item 7.
|
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Pounds Purchased
(in millions)
|
|
Market Price Range Per Pound
|
2014
|
177
|
|
$0.69 - $0.84
|
2013
|
172
|
|
$0.71 - $0.93
|
2012
|
177
|
|
$0.57 - $0.78
|
2011
|
205
|
|
$0.65 - $0.77
|
|
Pounds Purchased
(in millions)
|
|
Market Price Range Per Pound
|
2014
|
142
|
|
$0.55 - $0.82
|
2013
|
139
|
|
$0.44 - $1.01
|
2012
|
158
|
|
$0.84 - $1.98
|
2011
|
175
|
|
$0.86 - $1.77
|
|
Year Ended
November 30,
|
||||||
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
Segment Sales:
|
|
|
|
||||
Performance Chemicals
|
|
|
|
||||
Performance Materials
|
$
|
316.5
|
|
|
$
|
338.6
|
|
Specialty Chemicals
|
430.0
|
|
|
434.4
|
|
||
Total Performance Chemicals
|
$
|
746.5
|
|
|
$
|
773.0
|
|
|
|
|
|
||||
Engineered Surfaces
|
|
|
|
||||
Coated Fabrics
|
$
|
98.4
|
|
|
$
|
108.9
|
|
Laminates and Performance Films
|
142.7
|
|
|
136.2
|
|
||
Total Engineered Surfaces
|
241.1
|
|
|
245.1
|
|
||
Inter-segment sales
|
(.2
|
)
|
|
—
|
|
||
Consolidated Net Sales
|
$
|
987.4
|
|
|
$
|
1,018.1
|
|
|
|
|
|
||||
Segment Gross Profit:
|
|
|
|
||||
Performance Chemicals
|
$
|
141.1
|
|
|
$
|
155.4
|
|
Engineered Surfaces
|
58.3
|
|
|
57.3
|
|
||
Consolidated Gross Profit
|
$
|
199.4
|
|
|
$
|
212.7
|
|
|
|
|
|
||||
Segment Operating Profit:
|
|
|
|
||||
Performance Chemicals
|
$
|
46.2
|
|
|
$
|
64.1
|
|
Engineered Surfaces
|
19.2
|
|
|
15.6
|
|
||
Interest expense
|
(32.9
|
)
|
|
(31.9
|
)
|
||
Corporate expense
|
(20.0
|
)
|
|
(19.8
|
)
|
||
Debt issuance costs write-off
|
(.8
|
)
|
|
(1.5
|
)
|
||
Consolidated income from continuing operations before income tax
|
$
|
11.7
|
|
|
$
|
26.5
|
|
|
Year Ended
November 30,
|
||||||
|
2013
|
|
2012
|
||||
|
(Dollars in millions)
|
||||||
Segment Sales:
|
|
|
|
||||
Performance Chemicals
|
|
|
|
||||
Performance Materials
|
$
|
338.6
|
|
|
$
|
422.5
|
|
Specialty Chemicals
|
434.4
|
|
|
442.0
|
|
||
Total Performance Chemicals
|
$
|
773.0
|
|
|
$
|
864.5
|
|
|
|
|
|
||||
Engineered Surfaces
|
|
|
|
||||
Coated Fabrics
|
$108.9
|
|
$117.0
|
||||
Laminates and Performance Films
|
136.2
|
|
|
144.0
|
|
||
Total Engineered Surfaces
|
245.1
|
|
|
261.0
|
|
||
Consolidated Net Sales
|
$
|
1,018.1
|
|
|
$
|
1,125.5
|
|
|
|
|
|
||||
Segment Gross Profit:
|
|
|
|
||||
Performance Chemicals
|
$
|
155.4
|
|
|
$
|
177.2
|
|
Engineered Surfaces
|
57.3
|
|
|
50.0
|
|
||
Consolidated Gross Profit
|
$
|
212.7
|
|
|
$
|
227.2
|
|
|
|
|
|
||||
Segment Operating Profit:
|
|
|
|
||||
Performance Chemicals
|
$
|
64.1
|
|
|
$
|
89.6
|
|
Engineered Surfaces
|
15.6
|
|
|
3.8
|
|
||
Interest expense
|
(31.9
|
)
|
|
(36.5
|
)
|
||
Corporate expense
|
(19.8
|
)
|
|
(20.0
|
)
|
||
Debt issuance costs write-off
|
(1.5
|
)
|
|
—
|
|
||
Acquisition and integration related expenses
|
—
|
|
|
—
|
|
||
Consolidated income from continuing operations before income tax
|
$
|
26.5
|
|
|
$
|
36.9
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Cash provided by operating activities
|
$
|
15.0
|
|
|
$
|
45.8
|
|
|
$
|
65.3
|
|
Cash used in investing activities
|
$
|
(25.0
|
)
|
|
$
|
(22.0
|
)
|
|
$
|
(20.1
|
)
|
Cash used in financing activities
|
$
|
(52.5
|
)
|
|
$
|
(1.5
|
)
|
|
$
|
(2.9
|
)
|
(Decrease) increase in cash and cash equivalents
|
$
|
(65.4
|
)
|
|
$
|
21.9
|
|
|
$
|
44.1
|
|
|
Payments Due By Period
|
||||||||||||||||||
|
Total
|
|
Less
Than 1
Year
|
|
2 – 3
Years
|
|
4 – 5
Years
|
|
More
Than 5
Years
|
||||||||||
|
(Dollars in millions)
|
||||||||||||||||||
Long-term debt and amounts due banks
|
$
|
395.2
|
|
|
$
|
5.2
|
|
|
$
|
190.0
|
|
|
$
|
200.0
|
|
|
$
|
—
|
|
Capital lease obligations
(1)
|
27.0
|
|
|
1.1
|
|
|
2.6
|
|
|
2.8
|
|
|
20.5
|
|
|||||
Interest payments on long-term debt
(2)
|
79.2
|
|
|
23.8
|
|
|
47.5
|
|
|
7.9
|
|
|
—
|
|
|||||
Operating and financing leases
(3)
|
39.4
|
|
|
4.6
|
|
|
9.6
|
|
|
4.9
|
|
|
20.3
|
|
|||||
Purchase obligations
|
28.2
|
|
|
28.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Pension and post-retirement funding obligations
(4)
|
117.3
|
|
|
6.7
|
|
|
17.2
|
|
|
10.4
|
|
|
83.0
|
|
|||||
Other long-term liabilities
|
9.4
|
|
|
—
|
|
|
3.1
|
|
|
3.1
|
|
|
3.2
|
|
|||||
Total
|
$
|
695.7
|
|
|
$
|
69.6
|
|
|
$
|
270.0
|
|
|
$
|
229.1
|
|
|
$
|
127.0
|
|
(1)
|
Includes principal and effective interest payments.
|
(2)
|
Based on outstanding debt balances as of
November 30, 2014
and estimated interest rates. As those are based on estimates, actual future payments may be different.
|
(3)
|
Includes payments on the Company's corporate headquarters.
|
(4)
|
Payments are based on Company estimates and current funding laws. Actual results may be different.
|
•
|
Investment returns which differ materially from the Company’s
7.75%
return assumption for
2015
;
|
•
|
Significant changes in interest rates, affecting the discount rate; and
|
•
|
Opportunities to reduce future cash requirements by accelerating contributions ahead of the minimum required schedule. Voluntary contributions in excess of minimally required amounts may prevent the need for larger contributions in the future.
|
Item 7A.
|
|
Quantitative and Qualitative Disclosures About Market Risk
|
/s/ Ernst & Young LLP
|
|
Akron, Ohio
|
|
January 23, 2015
|
|
Item 8.
|
|
Consolidated Financial Statements and Supplementary Data
|
|
Page
Number
|
Consolidated Statements of Operations for the years ended November 30, 20
14, 2013, and 2012
|
|
Consolidated Statements of Comprehensive Income (Loss) for the years ended November 30, 2014, 2013, and 2012
|
|
/s/ Kevin M. McMullen
|
Kevin M. McMullen
|
Chairman, Chief Executive Officer and President
|
|
/s/ Paul F. DeSantis
|
Paul F. DeSantis
|
Senior Vice President and Chief Financial Officer
|
|
January 23, 2015
|
/s/ Ernst & Young LLP
|
|
Akron, Ohio
|
|
January 23, 2015
|
|
|
Years Ended November 30,
|
||||||||||
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions, except per share data)
|
||||||||||
Net Sales
|
$
|
987.4
|
|
|
$
|
1,018.1
|
|
|
$
|
1,125.5
|
|
Cost of goods sold (exclusive of depreciation)
|
788.0
|
|
|
805.4
|
|
|
898.3
|
|
|||
Gross profit
|
199.4
|
|
|
212.7
|
|
|
227.2
|
|
|||
Other Costs and Expenses:
|
|
|
|
|
|
||||||
Selling, general, and administrative
|
120.2
|
|
|
118.1
|
|
|
121.2
|
|
|||
Depreciation and amortization
|
34.8
|
|
|
33.6
|
|
|
32.0
|
|
|||
Asset impairment
|
—
|
|
|
.2
|
|
|
1.0
|
|
|||
Loss (gain) on asset sales
|
.5
|
|
|
(4.9
|
)
|
|
—
|
|
|||
Restructuring and severance
|
.9
|
|
|
7.1
|
|
|
1.0
|
|
|||
Interest expense
|
32.9
|
|
|
31.9
|
|
|
36.5
|
|
|||
Debt issuance costs write-off
|
.8
|
|
|
1.5
|
|
|
—
|
|
|||
Other income, net
|
(2.4
|
)
|
|
(1.3
|
)
|
|
(1.4
|
)
|
|||
Total Other Costs and Expenses
|
187.7
|
|
|
186.2
|
|
|
190.3
|
|
|||
Income from continuing operations before income taxes
|
11.7
|
|
|
26.5
|
|
|
36.9
|
|
|||
Income tax (benefit) expense
|
(.4
|
)
|
|
6.0
|
|
|
11.2
|
|
|||
Income from continuing operations
|
12.1
|
|
|
20.5
|
|
|
25.7
|
|
|||
Discontinued Operations:
|
|
|
|
|
|
||||||
Loss from discontinued operations (net of tax benefit of $0.4 million, $0.6 million and $0.9 million in 2014, 2013 and 2012, respectively)
|
(.6
|
)
|
|
(.9
|
)
|
|
(4.1
|
)
|
|||
Gain on sale of discontinued operations (net of tax expense of $3.9 million in 2012)
|
—
|
|
|
—
|
|
|
6.0
|
|
|||
(Loss) income from discontinued operations
|
$
|
(.6
|
)
|
|
$
|
(.9
|
)
|
|
$
|
1.9
|
|
Net income
|
$
|
11.5
|
|
|
$
|
19.6
|
|
|
$
|
27.6
|
|
Income Per Share—Basic
|
|
|
|
|
|
||||||
Income per share—continuing operations
|
$
|
.26
|
|
|
$
|
.44
|
|
|
$
|
.56
|
|
(Loss) income per share—discontinued operations
|
(.01
|
)
|
|
(.02
|
)
|
|
.05
|
|
|||
Basic income per share
|
$
|
.25
|
|
|
$
|
.42
|
|
|
$
|
.61
|
|
Income Per Share—Diluted
|
|
|
|
|
|
||||||
Income per share—continuing operations
|
$
|
.26
|
|
|
$
|
.44
|
|
|
$
|
.56
|
|
(Loss) income per share—discontinued operations
|
(.01
|
)
|
|
(.02
|
)
|
|
.04
|
|
|||
Diluted income per share
|
$
|
.25
|
|
|
$
|
.42
|
|
|
$
|
.60
|
|
|
|
|
|
|
|
||||||
Weighted average shares outstanding - Basic
|
46.3
|
|
|
46.1
|
|
|
45.6
|
|
|||
Weighted average shares outstanding - Diluted
|
47.1
|
|
|
46.6
|
|
|
46.0
|
|
|
Years Ended November 30,
|
||||||||||
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Net Income
|
$
|
11.5
|
|
|
$
|
19.6
|
|
|
$
|
27.6
|
|
|
|
|
|
|
|
||||||
Components of other comprehensive income (loss):
|
|
|
|
|
|
||||||
Foreign currency translations
|
|
|
|
|
|
||||||
Unrealized net change during the period
|
(5.4
|
)
|
|
(.6
|
)
|
|
(3.1
|
)
|
|||
Unrealized net change on intercompany foreign debt during the period
|
(7.5
|
)
|
|
4.1
|
|
|
(2.0
|
)
|
|||
Tax effect
|
2.4
|
|
|
(1.1
|
)
|
|
.8
|
|
|||
Foreign currency translations, net of tax
|
(10.5
|
)
|
|
2.4
|
|
|
(4.3
|
)
|
|||
|
|
|
|
|
|
||||||
Interest rate swap
|
|
|
|
|
|
||||||
Amortization of unrecognized gain on interest rate swap reclassified into interest expense, net of tax
|
—
|
|
|
—
|
|
|
1.3
|
|
|||
Tax effect
|
—
|
|
|
—
|
|
|
1.3
|
|
|||
Amortization of unrecognized gain on interest rate swap reclassified into interest expense
|
—
|
|
|
—
|
|
|
2.6
|
|
|||
|
|
|
|
|
|
||||||
Post-retirement benefit plans:
|
|
|
|
|
|
||||||
Actuarial net gain (loss):
|
|
|
|
|
|
||||||
Net (loss) gain arising during period
|
(50.7
|
)
|
|
35.5
|
|
|
(39.2
|
)
|
|||
Amortization of net loss included in net periodic pension expense
|
2.5
|
|
|
3.6
|
|
|
1.4
|
|
|||
Prior service credit:
|
|
|
|
|
|
||||||
Prior service credit arising during period
|
—
|
|
|
.1
|
|
|
—
|
|
|||
Amortization of prior service credits included in net period pension expense
|
(.3
|
)
|
|
(.3
|
)
|
|
(.3
|
)
|
|||
Tax effect
|
18.8
|
|
|
(15.2
|
)
|
|
15.4
|
|
|||
Defined benefit plans, net of tax
|
(29.7
|
)
|
|
23.7
|
|
|
(22.7
|
)
|
|||
Other comprehensive (loss) income, net of tax
|
(40.2
|
)
|
|
26.1
|
|
|
(24.4
|
)
|
|||
Comprehensive (loss) income
|
$
|
(28.7
|
)
|
|
$
|
45.7
|
|
|
$
|
3.2
|
|
|
November 30,
|
||||||
|
2014
|
|
2013
|
||||
|
(Dollars in millions, except
per share amounts)
|
||||||
ASSETS:
|
|
|
|
||||
Current Assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
99.5
|
|
|
$
|
164.9
|
|
Accounts receivable, net
|
135.7
|
|
|
123.1
|
|
||
Inventories
|
92.7
|
|
|
88.1
|
|
||
Prepaid expenses and other
|
21.0
|
|
|
17.6
|
|
||
Deferred income taxes - current
|
7.0
|
|
|
8.4
|
|
||
Total Current Assets
|
355.9
|
|
|
402.1
|
|
||
Property, plant, and equipment, net
|
238.4
|
|
|
226.5
|
|
||
Trademarks and other intangible assets, net
|
66.4
|
|
|
73.6
|
|
||
Goodwill
|
85.4
|
|
|
88.9
|
|
||
Deferred income taxes - non-current
|
68.2
|
|
|
46.9
|
|
||
Deferred financing fees
|
7.0
|
|
|
9.3
|
|
||
Other assets
|
7.9
|
|
|
7.4
|
|
||
Total Assets
|
$
|
829.2
|
|
|
$
|
854.7
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY:
|
|
|
|
||||
Current Liabilities
|
|
|
|
||||
Amounts due banks
|
$
|
5.6
|
|
|
$
|
4.6
|
|
Accounts payable
|
94.3
|
|
|
92.1
|
|
||
Accrued payroll and personal property taxes
|
17.8
|
|
|
20.4
|
|
||
Employee benefit obligations
|
2.9
|
|
|
2.1
|
|
||
Accrued interest
|
1.4
|
|
|
1.7
|
|
||
Other current liabilities
|
1.8
|
|
|
5.8
|
|
||
Total Current Liabilities
|
123.8
|
|
|
126.7
|
|
||
Senior notes
|
200.0
|
|
|
250.0
|
|
||
Long-term debt
|
206.4
|
|
|
194.0
|
|
||
Post-retirement benefits other than pensions
|
6.6
|
|
|
6.5
|
|
||
Pension liabilities
|
110.8
|
|
|
67.2
|
|
||
Deferred income taxes - non-current
|
21.6
|
|
|
23.3
|
|
||
Other liabilities
|
9.5
|
|
|
9.0
|
|
||
Total Liabilities
|
678.7
|
|
|
676.7
|
|
||
Shareholders’ Equity
|
|
|
|
||||
Preference stock - $1.00 par value; 15 million shares authorized; none outstanding
|
—
|
|
|
—
|
|
||
Common stock - $0.10 par value; 135 million shares authorized, 48.3 million and 47.9 million shares issued as of November 30, 2014 and 2013, respectively
|
4.8
|
|
|
4.8
|
|
||
Additional contributed capital
|
338.5
|
|
|
334.6
|
|
||
Retained deficit
|
(56.1
|
)
|
|
(67.6
|
)
|
||
Treasury stock at cost; 1.0 million and 0.7 million shares at November 30, 2014 and 2013, respectively
|
(7.9
|
)
|
|
(5.2
|
)
|
||
Accumulated other comprehensive loss
|
(128.8
|
)
|
|
(88.6
|
)
|
||
Total Shareholders’ Equity
|
150.5
|
|
|
178.0
|
|
||
Total Liabilities and Shareholders’ Equity
|
$
|
829.2
|
|
|
$
|
854.7
|
|
(Dollars and shares in millions)
|
Number of Common Shares Outstanding
|
|
Common
Stock
|
|
Additional
Contributed
Capital
|
|
Retained
Deficit
|
|
Treasury
Stock
|
|
Accumulated Other Comprehensive (Loss) Income
|
|
Total Shareholders’ Equity
|
|||||||||||||
Balance November 30, 2011
|
45.7
|
|
|
$
|
4.6
|
|
|
$
|
324.9
|
|
|
$
|
(114.8
|
)
|
|
$
|
(2.7
|
)
|
|
$
|
(90.3
|
)
|
|
$
|
121.7
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net income
|
|
|
|
|
|
|
27.6
|
|
|
|
|
|
|
27.6
|
|
|||||||||||
Cumulative translation adjustment (net of tax benefit of $0.8 million)
|
|
|
|
|
|
|
|
|
|
|
(4.3
|
)
|
|
(4.3
|
)
|
|||||||||||
Amortization of unrecognized loss on interest rate swap (net of tax benefit of $1.3 million)
|
|
|
|
|
|
|
|
|
|
|
2.6
|
|
|
2.6
|
|
|||||||||||
Defined benefit plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Prior service credits (net of tax benefit of $0.9 million)
|
|
|
|
|
|
|
|
|
|
|
.6
|
|
|
.6
|
|
|||||||||||
Net actuarial loss (net of tax benefit of $14.5 million)
|
|
|
|
|
|
|
|
|
|
|
(23.3
|
)
|
|
(23.3
|
)
|
|||||||||||
Common stock issuance
|
1.2
|
|
|
.1
|
|
|
6.9
|
|
|
|
|
(1.7
|
)
|
|
|
|
5.3
|
|
||||||||
Balance November 30, 2012
|
46.9
|
|
|
$
|
4.7
|
|
|
$
|
331.8
|
|
|
$
|
(87.2
|
)
|
|
$
|
(4.4
|
)
|
|
$
|
(114.7
|
)
|
|
$
|
130.2
|
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net income
|
|
|
|
|
|
|
19.6
|
|
|
|
|
|
|
19.6
|
|
|||||||||||
Cumulative translation adjustment (net of tax expense of $1.1 million)
|
|
|
|
|
|
|
|
|
|
|
2.4
|
|
|
2.4
|
|
|||||||||||
Defined benefit plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Prior service credits (net of tax benefit of $0.1 million)
|
|
|
|
|
|
|
|
|
|
|
(.1
|
)
|
|
(.1
|
)
|
|||||||||||
Net actuarial gain (net of tax expense of $15.2 million)
|
|
|
|
|
|
|
|
|
|
|
23.8
|
|
|
23.8
|
|
|||||||||||
Common stock issuance
|
.3
|
|
|
.1
|
|
|
2.8
|
|
|
|
|
(.8
|
)
|
|
|
|
2.1
|
|
||||||||
Balance November 30, 2013
|
47.2
|
|
|
$
|
4.8
|
|
|
$
|
334.6
|
|
|
$
|
(67.6
|
)
|
|
$
|
(5.2
|
)
|
|
$
|
(88.6
|
)
|
|
$
|
178.0
|
|
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net income
|
|
|
|
|
|
|
11.5
|
|
|
|
|
|
|
11.5
|
|
|||||||||||
Cumulative translation adjustment (net of tax benefit of $2.4 million)
|
|
|
|
|
|
|
|
|
|
|
(10.5
|
)
|
|
(10.5
|
)
|
|||||||||||
Defined benefit plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Prior service credits (net of tax benefit of $0.1 million)
|
|
|
|
|
|
|
|
|
|
|
(.2
|
)
|
|
(.2
|
)
|
|||||||||||
Net actuarial loss (net of tax benefit of $18.7 million)
|
|
|
|
|
|
|
|
|
|
|
(29.5
|
)
|
|
(29.5
|
)
|
|||||||||||
Common stock issuance
|
.3
|
|
|
|
|
|
3.9
|
|
|
|
|
(1.3
|
)
|
|
|
|
2.6
|
|
||||||||
Repurchase of treasury shares
|
(.2
|
)
|
|
|
|
|
|
|
|
(1.4
|
)
|
|
|
|
(1.4
|
)
|
||||||||||
Balance November 30, 2014
|
47.3
|
|
|
$
|
4.8
|
|
|
$
|
338.5
|
|
|
$
|
(56.1
|
)
|
|
$
|
(7.9
|
)
|
|
$
|
(128.8
|
)
|
|
$
|
150.5
|
|
|
Years Ended November 30,
|
||||||||||
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Operating Activities
|
|
|
|
|
|
||||||
Net income
|
$
|
11.5
|
|
|
$
|
19.6
|
|
|
$
|
27.6
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
Loss (gain) on disposal of fixed assets
|
.5
|
|
|
(4.9
|
)
|
|
—
|
|
|||
Depreciation and amortization
|
34.8
|
|
|
33.6
|
|
|
32.0
|
|
|||
Amortization & write-off of debt issuance costs
|
3.3
|
|
|
2.8
|
|
|
2.7
|
|
|||
Gain on sale of business
|
—
|
|
|
—
|
|
|
(9.9
|
)
|
|||
Impairment of long-lived assets
|
—
|
|
|
.2
|
|
|
1.0
|
|
|||
Proceeds from insurance settlements
|
—
|
|
|
.8
|
|
|
—
|
|
|||
Non-cash stock compensation expense
|
2.7
|
|
|
2.2
|
|
|
4.5
|
|
|||
Provision for uncollectible accounts
|
.3
|
|
|
—
|
|
|
.6
|
|
|||
Provision for obsolete inventories
|
.2
|
|
|
1.5
|
|
|
—
|
|
|||
Deferred income taxes
|
(5.1
|
)
|
|
3.9
|
|
|
8.6
|
|
|||
Other
|
—
|
|
|
(.2
|
)
|
|
.6
|
|
|||
Changes in operating assets and liabilities:
|
|
|
|
|
|
||||||
Accounts receivable
|
(12.3
|
)
|
|
2.8
|
|
|
31.7
|
|
|||
Inventories
|
(6.8
|
)
|
|
5.9
|
|
|
(15.6
|
)
|
|||
Other current assets
|
(8.1
|
)
|
|
(.9
|
)
|
|
(.4
|
)
|
|||
Current liabilities
|
.2
|
|
|
(10.6
|
)
|
|
(14.0
|
)
|
|||
Other non-current assets
|
(17.3
|
)
|
|
11.0
|
|
|
2.5
|
|
|||
Other non-current liabilities
|
15.2
|
|
|
(13.0
|
)
|
|
5.7
|
|
|||
Contribution to defined benefit plan
|
(4.1
|
)
|
|
(8.8
|
)
|
|
(18.7
|
)
|
|||
Discontinued operations
|
—
|
|
|
(.1
|
)
|
|
6.4
|
|
|||
Net Cash Provided By Operating Activities
|
15.0
|
|
|
45.8
|
|
|
65.3
|
|
|||
Investing Activities
|
|
|
|
|
|
||||||
Capital expenditures
|
(29.8
|
)
|
|
(28.9
|
)
|
|
(32.8
|
)
|
|||
Proceeds from note receivable
|
2.3
|
|
|
—
|
|
|
—
|
|
|||
Proceeds from sale of businesses
|
—
|
|
|
—
|
|
|
12.4
|
|
|||
Proceeds from insurance settlements
|
2.4
|
|
|
.2
|
|
|
—
|
|
|||
Proceeds from asset sales
|
.1
|
|
|
6.7
|
|
|
.3
|
|
|||
Net Cash Used In Investing Activities
|
(25.0
|
)
|
|
(22.0
|
)
|
|
(20.1
|
)
|
|||
Financing Activities
|
|
|
|
|
|
||||||
Repayment of debt obligations
|
(52.0
|
)
|
|
(2.0
|
)
|
|
(2.0
|
)
|
|||
Short-term debt borrowings
|
23.3
|
|
|
34.9
|
|
|
43.8
|
|
|||
Short-term debt payments
|
(22.7
|
)
|
|
(39.4
|
)
|
|
(45.4
|
)
|
|||
Payments for debt refinancing
|
—
|
|
|
(.6
|
)
|
|
—
|
|
|||
Restricted cash
|
—
|
|
|
5.5
|
|
|
(1.3
|
)
|
|||
Purchase of treasury shares
|
(1.4
|
)
|
|
—
|
|
|
—
|
|
|||
Cash received from exercise of stock options
|
.3
|
|
|
.1
|
|
|
2.0
|
|
|||
Net Cash Used In Financing Activities
|
(52.5
|
)
|
|
(1.5
|
)
|
|
(2.9
|
)
|
|||
Effect of exchange rate changes on cash
|
(2.9
|
)
|
|
(.4
|
)
|
|
1.8
|
|
|||
Net (Decrease) Increase in Cash and Cash Equivalents
|
(65.4
|
)
|
|
21.9
|
|
|
44.1
|
|
|||
Cash and cash equivalents at beginning of period
|
164.9
|
|
|
143.0
|
|
|
98.9
|
|
|||
Cash and Cash Equivalents at End of Period
|
$
|
99.5
|
|
|
$
|
164.9
|
|
|
$
|
143.0
|
|
Supplemental Cash Flow Information
|
|
|
|
|
|
||||||
Capital lease obligations incurred
|
$
|
14.5
|
|
|
$
|
3.0
|
|
|
$
|
—
|
|
Cash paid for:
|
|
|
|
|
|
||||||
Interest
|
$
|
30.9
|
|
|
$
|
29.7
|
|
|
$
|
32.6
|
|
Income taxes
|
$
|
3.9
|
|
|
$
|
4.4
|
|
|
$
|
6.5
|
|
•
|
Level 1—Quoted prices in active markets for identical assets or liabilities.
|
•
|
Level 2—Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in an active market, quoted prices in markets that are not active, and model-derived valuations in which all significant inputs are observable or can be corroborated by observable market data.
|
•
|
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
|
|
Years
|
Buildings
|
25 – 40
|
Machinery and equipment
|
5 – 15
|
Furniture and fixtures
|
3 – 10
|
Software
|
3 – 5
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Severance expense
|
$
|
.8
|
|
|
$
|
4.5
|
|
|
$
|
.5
|
|
Closure costs
|
.1
|
|
|
2.6
|
|
|
.5
|
|
|||
Total
|
$
|
.9
|
|
|
$
|
7.1
|
|
|
$
|
1.0
|
|
|
November 30,
|
|
2014
|
|
November 30,
|
||||||||||
|
2013
|
Provision
|
|
Payments
|
|
2014
|
|||||||||
|
(Dollars in millions)
|
||||||||||||||
Performance Chemicals
|
$
|
—
|
|
|
$
|
.5
|
|
|
$
|
.5
|
|
|
$
|
—
|
|
Engineered Surfaces
|
.2
|
|
|
.4
|
|
|
.6
|
|
|
—
|
|
||||
Corporate
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total
|
$
|
.2
|
|
|
$
|
.9
|
|
|
$
|
1.1
|
|
|
$
|
—
|
|
|
Years Ended November 30,
|
||||||||||
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Income (Loss) from Continuing Operations Before Income Taxes
|
|
|
|
|
|
||||||
U.S.
|
$
|
(1.7
|
)
|
|
$
|
13.6
|
|
|
$
|
21.7
|
|
Foreign
|
13.4
|
|
|
12.9
|
|
|
15.2
|
|
|||
|
$
|
11.7
|
|
|
$
|
26.5
|
|
|
$
|
36.9
|
|
|
Years Ended November 30,
|
||||||||||
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Income Tax Expense (Benefit)
|
|
|
|
|
|
||||||
Current
|
|
|
|
|
|
||||||
U.S. Federal
|
$
|
—
|
|
|
$
|
(1.1
|
)
|
|
$
|
—
|
|
U.S. State and Local
|
.2
|
|
|
.2
|
|
|
.1
|
|
|||
Foreign
|
4.5
|
|
|
3.0
|
|
|
2.5
|
|
|||
|
4.7
|
|
|
2.1
|
|
|
2.6
|
|
|||
Deferred
|
|
|
|
|
|
||||||
U.S. Federal
|
(5.6
|
)
|
|
6.1
|
|
|
7.0
|
|
|||
U.S. State and Local
|
.3
|
|
|
.9
|
|
|
(.6
|
)
|
|||
Foreign
|
.2
|
|
|
(3.1
|
)
|
|
2.2
|
|
|||
|
(5.1
|
)
|
|
3.9
|
|
|
8.6
|
|
|||
Income Tax Expense (Benefit)
|
$
|
(.4
|
)
|
|
$
|
6.0
|
|
|
$
|
11.2
|
|
|
Years Ended November 30,
|
|||||||
|
2014
|
|
2013
|
|
2012
|
|||
Effective Income Tax Rate
|
|
|
|
|
|
|||
Tax at Federal statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
Valuation allowance (reversal)
|
(49.7
|
)
|
|
.4
|
|
|
.7
|
|
Foreign taxes at different rates
|
(22.5
|
)
|
|
(11.2
|
)
|
|
(3.7
|
)
|
Permanent items
|
4.2
|
|
|
2.3
|
|
|
1.2
|
|
U. S. tax deemed dividend
|
10.8
|
|
|
—
|
|
|
—
|
|
Non-deductible executive compensation
|
2.4
|
|
|
3.7
|
|
|
1.0
|
|
Changes in deferred taxes
|
6.6
|
|
|
.7
|
|
|
4.6
|
|
Uncertain tax positions
|
—
|
|
|
(7.6
|
)
|
|
(4.3
|
)
|
State taxes
|
4.2
|
|
|
4.1
|
|
|
.7
|
|
Foreign withholding tax
|
5.5
|
|
|
—
|
|
|
—
|
|
Foreign stock sale
|
—
|
|
|
(2.2
|
)
|
|
—
|
|
Tax credits
|
(3.0
|
)
|
|
(3.7
|
)
|
|
(2.1
|
)
|
Other, net
|
3.1
|
|
|
1.1
|
|
|
(2.8
|
)
|
Effective Income Tax Rate
|
(3.4
|
)%
|
|
22.6
|
%
|
|
30.3
|
%
|
|
November 30,
|
||||||||||||||
|
2014
|
|
2013
|
||||||||||||
(Dollars in millions)
|
Assets
|
|
Liabilities
|
|
Assets
|
|
Liabilities
|
||||||||
Accrued estimated costs
|
$
|
7.0
|
|
|
$
|
—
|
|
|
$
|
9.1
|
|
|
$
|
—
|
|
Goodwill and intangible assets
|
—
|
|
|
26.7
|
|
|
—
|
|
|
29.3
|
|
||||
Depreciation
|
—
|
|
|
20.0
|
|
|
—
|
|
|
22.5
|
|
||||
Pension
|
40.5
|
|
|
—
|
|
|
23.6
|
|
|
—
|
|
||||
NOLC’s and other carryforwards
|
57.4
|
|
|
—
|
|
|
62.2
|
|
|
—
|
|
||||
Post-retirement employee benefits
|
5.5
|
|
|
—
|
|
|
5.0
|
|
|
—
|
|
||||
Other
|
1.0
|
|
|
—
|
|
|
—
|
|
|
.1
|
|
||||
Valuation allowance
|
(11.1
|
)
|
|
—
|
|
|
(16.0
|
)
|
|
—
|
|
||||
Deferred Taxes
|
$
|
100.3
|
|
|
$
|
46.7
|
|
|
$
|
83.9
|
|
|
$
|
51.9
|
|
|
Years Ended November 30,
|
||||||||||
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Opening balance December 1
|
$
|
.8
|
|
|
$
|
4.3
|
|
|
$
|
10.6
|
|
Increase based on tax positions related to prior year
|
—
|
|
|
—
|
|
|
1.0
|
|
|||
Decrease based on tax positions in the prior year
|
—
|
|
|
(.4
|
)
|
|
(3.3
|
)
|
|||
Reduction due to lapse of statue of limitations
|
(.2
|
)
|
|
(3.1
|
)
|
|
(3.7
|
)
|
|||
Currency translation effects
|
—
|
|
|
—
|
|
|
(.3
|
)
|
|||
Ending balance November 30
|
$
|
.6
|
|
|
$
|
.8
|
|
|
$
|
4.3
|
|
|
November 30,
|
||||||||||
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Foreign currency translation adjustments
|
$
|
(10.3
|
)
|
|
$
|
.2
|
|
|
$
|
(2.2
|
)
|
Unrecognized loss on interest rate swap
|
—
|
|
|
—
|
|
|
—
|
|
|||
Employee benefit plans
|
(118.5
|
)
|
|
(88.8
|
)
|
|
(112.5
|
)
|
|||
Accumulated other comprehensive loss
|
$
|
(128.8
|
)
|
|
$
|
(88.6
|
)
|
|
$
|
(114.7
|
)
|
|
Foreign Currency Items
|
|
Unrealized Loss on Interest Rate Swap
|
|
Defined Benefit Plans
|
|
Accumulated Other Comprehensive Loss
|
||||||||
|
(Dollars in millions)
|
||||||||||||||
Balance November 30, 2011
|
$
|
2.1
|
|
|
$
|
(2.6
|
)
|
|
$
|
(89.8
|
)
|
|
$
|
(90.3
|
)
|
|
|
|
|
|
|
|
|
||||||||
Other comprehensive earnings (loss) before reclassifications
|
(4.3
|
)
|
|
—
|
|
|
(23.4
|
)
|
|
(27.7
|
)
|
||||
Amounts reclassified from accumulated other comprehensive earnings (loss)
|
—
|
|
|
2.6
|
|
|
.7
|
|
|
3.3
|
|
||||
Balance November 30, 2012
|
$
|
(2.2
|
)
|
|
$
|
—
|
|
|
$
|
(112.5
|
)
|
|
$
|
(114.7
|
)
|
|
|
|
|
|
|
|
|
||||||||
Other comprehensive earnings (loss) before reclassifications
|
2.4
|
|
|
—
|
|
|
21.4
|
|
|
23.8
|
|
||||
Amounts reclassified from accumulated other comprehensive earnings (loss)
|
—
|
|
|
—
|
|
|
2.3
|
|
|
2.3
|
|
||||
Balance November 30, 2013
|
$
|
.2
|
|
|
$
|
—
|
|
|
$
|
(88.8
|
)
|
|
$
|
(88.6
|
)
|
|
|
|
|
|
|
|
|
||||||||
Other comprehensive earnings (loss) before reclassifications
|
(10.5
|
)
|
|
—
|
|
|
(31.0
|
)
|
|
(41.5
|
)
|
||||
Amounts reclassified from accumulated other comprehensive earnings (loss)
|
—
|
|
|
—
|
|
|
1.3
|
|
|
1.3
|
|
||||
Balance November 30, 2014
|
$
|
(10.3
|
)
|
|
$
|
—
|
|
|
$
|
(118.5
|
)
|
|
$
|
(128.8
|
)
|
|
Years Ended November 30,
|
||||||||||
|
2014
|
|
2013
|
|
2012
|
||||||
Basic Earnings Per Share:
|
|
|
|
|
|
||||||
Income from continuing operations
|
$
|
12.1
|
|
|
$
|
20.5
|
|
|
$
|
25.7
|
|
Income from continuing operations allocated to participating securities
|
—
|
|
|
—
|
|
|
.1
|
|
|||
Income from continuing operations allocated to common stockholders
|
$
|
12.1
|
|
|
$
|
20.5
|
|
|
$
|
25.6
|
|
(Loss) income from discontinued operations
|
$
|
(.6
|
)
|
|
$
|
(.9
|
)
|
|
$
|
1.9
|
|
(Loss) income from discontinued operations allocated to participating securities
|
—
|
|
|
—
|
|
|
—
|
|
|||
(Loss) income from discontinued operations allocated to common stockholders
|
$
|
(.6
|
)
|
|
$
|
(.9
|
)
|
|
$
|
1.9
|
|
Net income
|
$
|
11.5
|
|
|
$
|
19.6
|
|
|
$
|
27.6
|
|
Net income allocated to participating securities
|
—
|
|
|
—
|
|
|
.1
|
|
|||
Net income allocated to common stockholders
|
$
|
11.5
|
|
|
$
|
19.6
|
|
|
$
|
27.5
|
|
Weighted-average common shares outstanding – basic
|
46.3
|
|
|
46.1
|
|
|
45.6
|
|
|||
Income from continuing operations per common share – basic
|
$
|
.26
|
|
|
$
|
.44
|
|
|
$
|
.56
|
|
(Loss) income from discontinued operations per common share – basic
|
$
|
(.01
|
)
|
|
$
|
(.02
|
)
|
|
$
|
.05
|
|
Net income per common share – basic
|
$
|
.25
|
|
|
$
|
.42
|
|
|
$
|
.61
|
|
Diluted Earnings Per Share:
|
|
|
|
|
|
||||||
Income from continuing operations
|
$
|
12.1
|
|
|
$
|
20.5
|
|
|
$
|
25.7
|
|
Income from continuing operations allocated to participating securities
|
—
|
|
|
—
|
|
|
.1
|
|
|||
Income from continuing operations allocated to common stockholders
|
$
|
12.1
|
|
|
$
|
20.5
|
|
|
$
|
25.6
|
|
(Loss) income from discontinued operations
|
$
|
(.6
|
)
|
|
$
|
(.9
|
)
|
|
$
|
1.9
|
|
(Loss) income from discontinued operations allocated to participating securities
|
—
|
|
|
—
|
|
|
—
|
|
|||
(Loss) income from discontinued operations allocated to common stockholders
|
$
|
(.6
|
)
|
|
$
|
(.9
|
)
|
|
$
|
1.9
|
|
Net income
|
$
|
11.5
|
|
|
$
|
19.6
|
|
|
$
|
27.6
|
|
Net income allocated to participating securities
|
—
|
|
|
—
|
|
|
.1
|
|
|||
Net income allocated to common stockholders
|
$
|
11.5
|
|
|
$
|
19.6
|
|
|
$
|
27.5
|
|
Weighted-average common shares outstanding – basic
|
46.3
|
|
|
46.1
|
|
|
45.6
|
|
|||
Dilutive effect of stock options
|
.8
|
|
|
.5
|
|
|
.4
|
|
|||
Weighted-average common shares outstanding – assuming dilution
|
47.1
|
|
|
46.6
|
|
|
46.0
|
|
|||
Income from continuing operations per common share – assuming dilution
|
$
|
.26
|
|
|
$
|
.44
|
|
|
$
|
.56
|
|
(Loss) income from discontinued operations per common share – assuming dilution
|
$
|
(.01
|
)
|
|
$
|
(.02
|
)
|
|
$
|
.04
|
|
Net income per common share – assuming dilution
|
$
|
.25
|
|
|
$
|
.42
|
|
|
$
|
.60
|
|
|
Years Ended November 30,
|
|||||||
|
2014
|
|
2013
|
|
2012
|
|||
Weighted-average common shares outstanding
|
46.3
|
|
|
46.1
|
|
|
45.4
|
|
Weighted-average participating shares outstanding
|
—
|
|
|
—
|
|
|
.2
|
|
Total weighted-average shares outstanding—basic
|
46.3
|
|
|
46.1
|
|
|
45.6
|
|
Dilutive effect of stock options
|
.8
|
|
|
.5
|
|
|
.4
|
|
Total weighted-average shares outstanding—assuming dilution
|
47.1
|
|
|
46.6
|
|
|
46.0
|
|
|
November 30,
|
||||||
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
Raw materials and supplies
|
$
|
41.7
|
|
|
$
|
40.1
|
|
Work-in-process
|
6.6
|
|
|
5.6
|
|
||
Finished products
|
72.5
|
|
|
72.3
|
|
||
Acquired cost of inventories
|
120.8
|
|
|
118.0
|
|
||
Excess of acquired cost over LIFO cost
|
(20.5
|
)
|
|
(21.7
|
)
|
||
Obsolescence reserves
|
(7.6
|
)
|
|
(8.2
|
)
|
||
Inventories
|
$
|
92.7
|
|
|
$
|
88.1
|
|
|
November 30,
|
||||||
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
Land
|
$
|
17.7
|
|
|
$
|
17.9
|
|
Building and improvements
|
141.2
|
|
|
127.7
|
|
||
Machinery and equipment
|
411.6
|
|
|
397.6
|
|
||
Construction in progress
|
26.8
|
|
|
32.8
|
|
||
|
597.3
|
|
|
576.0
|
|
||
Accumulated depreciation
|
(358.9
|
)
|
|
(349.5
|
)
|
||
Property, Plant, and Equipment, Net
|
$
|
238.4
|
|
|
$
|
226.5
|
|
|
(Dollars in millions)
|
||
Balance November 30, 2012
|
$
|
86.7
|
|
Currency translation adjustment
|
2.2
|
|
|
Balance November 30, 2013
|
88.9
|
|
|
Currency translation adjustment
|
(3.5
|
)
|
|
Balance November 30, 2014
|
$
|
85.4
|
|
|
November 30, 2014
|
|
November 30, 2013
|
|
Weighted Average Life at
|
||||||||||||
|
Gross
Carrying Amount |
|
Accumulated
Amortization |
|
Gross
Carrying Amount |
|
Accumulated
Amortization |
|
November 30, 2014
|
||||||||
|
(Dollars in millions)
|
|
|
||||||||||||||
Finite-lived intangible assets
|
|
|
|
|
|
|
|
|
|
||||||||
Patents
|
$
|
21.3
|
|
|
$
|
17.1
|
|
|
$
|
22.3
|
|
|
$
|
15.7
|
|
|
2.8
|
Trademarks
|
7.5
|
|
|
6.9
|
|
|
7.5
|
|
|
6.6
|
|
|
5.4
|
||||
Technical know-how
|
5.1
|
|
|
4.2
|
|
|
5.1
|
|
|
4.2
|
|
|
24.1
|
||||
Customer lists
|
36.6
|
|
|
12.0
|
|
|
38.7
|
|
|
9.7
|
|
|
10.0
|
||||
Land use rights
|
6.4
|
|
|
1.0
|
|
|
6.4
|
|
|
.9
|
|
|
53.4
|
||||
Other
|
1.9
|
|
|
1.9
|
|
|
1.9
|
|
|
1.9
|
|
|
0.0
|
||||
|
$
|
78.8
|
|
|
$
|
43.1
|
|
|
$
|
81.9
|
|
|
$
|
39.0
|
|
|
15.4
|
Indefinite lived intangible assets
|
|
|
|
|
|
|
|
|
|
||||||||
Trademarks
|
30.7
|
|
|
—
|
|
|
30.7
|
|
|
—
|
|
|
N/A
|
||||
Total intangible assets
|
$
|
109.5
|
|
|
$
|
43.1
|
|
|
$
|
112.6
|
|
|
$
|
39.0
|
|
|
|
|
November 30,
|
||||||
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
|
|
|
|
||||
Capital lease obligations
|
$
|
.4
|
|
|
$
|
—
|
|
$200 million Term Loan B – current portion (interest at 4.25%)
|
2.0
|
|
|
2.0
|
|
||
Foreign subsidiaries borrowings (interest at 10.2% - 12.9%)
|
3.2
|
|
|
2.6
|
|
||
Total
|
$
|
5.6
|
|
|
$
|
4.6
|
|
|
November 30,
|
||||||
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
$200 million Term Loan B (interest at 4.25%)
|
$
|
192.0
|
|
|
$
|
194.0
|
|
Senior Unsecured Notes (interest at 7.875%)
|
200.0
|
|
|
250.0
|
|
||
Capital lease obligations
|
17.2
|
|
|
3.0
|
|
||
Senior Revolving Credit Facility (interest at 1.9%)
|
—
|
|
|
—
|
|
||
|
409.2
|
|
|
447.0
|
|
||
Less: current portion
|
(2.0
|
)
|
|
(2.0
|
)
|
||
Unamortized original issue discount
|
(.8
|
)
|
|
(1.0
|
)
|
||
Total long-term Debt
|
$
|
406.4
|
|
|
$
|
444.0
|
|
Year Ending November 30:
|
(Dollars in millions)
|
||
2015
|
$
|
1.1
|
|
2016
|
1.2
|
|
|
2017
|
1.5
|
|
|
2018
|
1.5
|
|
|
2019
|
1.5
|
|
|
Thereafter
|
21.0
|
|
|
Total minimum lease payments
|
27.8
|
|
|
Less: Amount representing estimated executory costs
|
(.7
|
)
|
|
Net minimum lease payments
|
27.1
|
|
|
Less: Amount representing interest
|
(9.5
|
)
|
|
Present value of minimum lease payments
|
$
|
17.6
|
|
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
Change in Benefit Obligation
|
|
|
|
||||
Benefit obligation at beginning of year
|
$
|
284.0
|
|
|
$
|
306.4
|
|
Service cost
|
1.5
|
|
|
1.7
|
|
||
Interest cost
|
13.1
|
|
|
12.3
|
|
||
Amendments
|
—
|
|
|
(.1
|
)
|
||
Actuarial loss (gain)
|
52.5
|
|
|
(20.6
|
)
|
||
Benefits paid net of retiree contributions
|
(16.1
|
)
|
|
(16.2
|
)
|
||
Exchange rate changes
|
(1.2
|
)
|
|
.5
|
|
||
Benefit Obligation at End of Year
|
$
|
333.8
|
|
|
$
|
284.0
|
|
|
|
|
|
||||
Change in Plan Assets
|
|
|
|
||||
Fair value of plan assets at beginning of year
|
$
|
216.3
|
|
|
$
|
194.3
|
|
Actual return on assets
|
16.3
|
|
|
28.8
|
|
||
Employer contributions
|
4.1
|
|
|
8.8
|
|
||
Employee contributions
|
.4
|
|
|
.6
|
|
||
Plan combinations
|
.8
|
|
|
—
|
|
||
Benefits and expenses paid net of retiree contributions
|
(16.1
|
)
|
|
(16.2
|
)
|
||
Fair Value of Plan Assets at End of Year
|
$
|
221.8
|
|
|
$
|
216.3
|
|
Funded Status at November 30
|
$
|
(112.0
|
)
|
|
$
|
(67.7
|
)
|
Amounts Recognized in the Consolidated Balance Sheets
|
|
|
|
||||
Current liability
|
$
|
(1.2
|
)
|
|
$
|
(.5
|
)
|
Non-current liability
|
(110.8
|
)
|
|
(67.2
|
)
|
||
Net Amount Recognized
|
$
|
(112.0
|
)
|
|
$
|
(67.7
|
)
|
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
Net actuarial loss
|
$
|
(159.9
|
)
|
|
$
|
(114.0
|
)
|
Prior service credits
|
$
|
.1
|
|
|
$
|
.1
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Net Periodic Benefit Cost
|
|
|
|
|
|
||||||
Service costs for benefits earned
|
$
|
1.5
|
|
|
$
|
1.7
|
|
|
$
|
1.5
|
|
Interest costs on benefit obligation
|
13.1
|
|
|
12.3
|
|
|
13.8
|
|
|||
Assumed return on plan assets
|
(14.9
|
)
|
|
(14.7
|
)
|
|
(14.2
|
)
|
|||
Amortization of net loss
|
3.9
|
|
|
5.0
|
|
|
3.0
|
|
|||
Total
|
$
|
3.6
|
|
|
$
|
4.3
|
|
|
$
|
4.1
|
|
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
U.S. Pension Plans
|
|
|
|
||||
Projected benefit obligation
|
$
|
320.5
|
|
|
$
|
271.4
|
|
Accumulated benefit obligation
|
$
|
320.5
|
|
|
$
|
271.4
|
|
Fair value of plan assets
|
$
|
220.7
|
|
|
$
|
216.0
|
|
Non-U.S. Pension Plans
|
|
|
|
||||
Projected benefit obligation
|
$
|
13.3
|
|
|
$
|
12.4
|
|
Accumulated benefit obligation
|
$
|
9.8
|
|
|
$
|
9.5
|
|
Fair value of plan assets
|
$
|
1.1
|
|
|
$
|
.3
|
|
|
Pension Plans
|
||||
|
2014
|
|
2013
|
||
Weighted Average Assumptions
|
|
|
|
||
Discount rate used for liability determination
|
4.01
|
%
|
|
4.74
|
%
|
Annual rates of salary increase (non-U.S. plans)
|
3.67
|
%
|
|
3.56
|
%
|
Measurement date
|
11/30
|
|
|
11/30
|
|
Asset
Category
|
Target
Allocation |
|
Percentage of Plan Assets
At November 30, |
|
Weighted-Average Expected Long-Term Rate Of Return
|
||||||
2014
|
2014
|
|
2013
|
|
|||||||
Equity securities
|
54
|
%
|
|
56
|
%
|
|
56
|
%
|
|
5.8
|
%
|
Fixed income securities
|
28
|
%
|
|
31
|
%
|
|
27
|
%
|
|
2.1
|
%
|
Real estate partnerships
|
4
|
%
|
|
2
|
%
|
|
2
|
%
|
|
.4
|
%
|
Other
|
14
|
%
|
|
11
|
%
|
|
15
|
%
|
|
1.8
|
%
|
Total
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
7.75
|
%
|
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
2014
|
|
|
|
(Dollars in millions)
|
|
|
||||||||||
Money market funds
|
|
$
|
.7
|
|
|
$
|
.7
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Registered investment companies:
|
|
|
|
|
|
|
|
|
||||||||
Equity mutual funds
|
|
123.1
|
|
|
123.1
|
|
|
—
|
|
|
—
|
|
||||
Fixed income mutual funds
|
|
69.5
|
|
|
69.5
|
|
|
—
|
|
|
—
|
|
||||
Total registered Investment companies
|
|
192.6
|
|
|
192.6
|
|
|
—
|
|
|
—
|
|
||||
Collective trust funds:
|
|
|
|
|
|
|
|
|
||||||||
Collateralized loan obligations
|
|
22.9
|
|
|
—
|
|
|
—
|
|
|
22.9
|
|
||||
Total collective trust funds
|
|
22.9
|
|
|
—
|
|
|
—
|
|
|
22.9
|
|
||||
Real estate partnerships
|
|
4.5
|
|
|
—
|
|
|
—
|
|
|
4.5
|
|
||||
|
|
$
|
220.7
|
|
|
$
|
193.3
|
|
|
$
|
—
|
|
|
$
|
27.4
|
|
|
|
|
|
|
|
|
|
|
||||||||
2013
|
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
|
$
|
.6
|
|
|
$
|
.6
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Registered investment companies:
|
|
|
|
|
|
|
|
|
||||||||
Equity mutual funds
|
|
120.5
|
|
|
120.5
|
|
|
—
|
|
|
—
|
|
||||
Fixed income mutual funds
|
|
57.4
|
|
|
57.4
|
|
|
—
|
|
|
—
|
|
||||
Total registered Investment companies
|
|
177.9
|
|
|
177.9
|
|
|
—
|
|
|
—
|
|
||||
Collective trust funds:
|
|
|
|
|
|
|
|
|
||||||||
Collateralized loan obligations
|
|
32.4
|
|
|
—
|
|
|
—
|
|
|
32.4
|
|
||||
Total collective trust funds
|
|
32.4
|
|
|
—
|
|
|
—
|
|
|
32.4
|
|
||||
Real estate partnerships
|
|
5.1
|
|
|
—
|
|
|
—
|
|
|
5.1
|
|
||||
|
|
$
|
216.0
|
|
|
$
|
178.5
|
|
|
$
|
—
|
|
|
$
|
37.5
|
|
|
Total
|
|
Collective
Trusts
|
|
Real Estate
Partnerships
|
||||||
|
(Dollars in millions)
|
||||||||||
Beginning balance, December 1, 2012
|
$
|
37.7
|
|
|
$
|
31.2
|
|
|
$
|
6.5
|
|
Redemptions
|
(1.6
|
)
|
|
(1.0
|
)
|
|
(.6
|
)
|
|||
Total gains or losses included in funded status
|
1.4
|
|
|
2.2
|
|
|
(.8
|
)
|
|||
Ending balance, November 30, 2013
|
$
|
37.5
|
|
|
$
|
32.4
|
|
|
$
|
5.1
|
|
Redemptions
|
(12.0
|
)
|
|
(12.0
|
)
|
|
—
|
|
|||
Total gains or losses included in funded status
|
1.9
|
|
|
2.5
|
|
|
(.6
|
)
|
|||
Ending balance, November 30, 2014
|
$
|
27.4
|
|
|
$
|
22.9
|
|
|
$
|
4.5
|
|
Financial Assets
|
|
Fair Value
|
|
Valuation Techniques
|
|
Unobservable Inputs
|
|
Ranges
|
|
|
(Dollars in Millions)
|
|
|
|
|
|
|
Real estate partnerships
|
|
$4.5
|
|
Discounted cash flow analysis
|
|
Discount rate
|
|
6.75% - 13.0%
|
|
|
|
|
|
|
Exit capitalization rate
|
|
6.43% - 10.0%
|
|
|
|
|
|
|
DCF term (years)
|
|
10 - 12
|
|
|
—
|
|
Appraisals
|
|
Comparable sales
|
|
N/A
|
|
|
$4.5
|
|
|
|
|
|
|
|
Fair Value
|
||
SEI Structured Credit Collective Fund
(a)
|
$
|
22.9
|
|
(a)
|
The SEI Structured Credit Collective Fund seeks to provide high general returns by investing in collateralized debt obligations (“CDO’s”) and other structured credit instruments. The SEI Structured Credit Collective Fund requires a
two
-year non-redemption period after which investments can be redeemed at any time; however, a
90
day redemption notification period is required. The Plan has satisfied all funding obligations related to this investment and has surpassed the
two
-year non-redemption period.
|
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
Change in Benefit Obligation
|
|
|
|
||||
Benefit obligation at beginning of year
|
$
|
7.2
|
|
|
$
|
8.5
|
|
Interest cost
|
.3
|
|
|
.3
|
|
||
Actuarial loss (gain)
|
.8
|
|
|
(.9
|
)
|
||
Benefits paid net of retiree contributions
|
(1.2
|
)
|
|
(.7
|
)
|
||
Benefit Obligation at End of Year
|
$
|
7.1
|
|
|
$
|
7.2
|
|
Change in Plan Assets
|
|
|
|
||||
Fair value of plan assets at beginning of year
|
$
|
—
|
|
|
$
|
—
|
|
Employer contributions
|
1.2
|
|
|
.7
|
|
||
Benefits and expenses paid, net of retiree contributions
|
(1.2
|
)
|
|
(.7
|
)
|
||
Fair Value of Plan Assets at End of Year
|
$
|
—
|
|
|
$
|
—
|
|
Funded Status at November 30
|
$
|
(7.1
|
)
|
|
$
|
(7.2
|
)
|
Amounts Recognized in the Consolidated Balance Sheets
|
|
|
|
||||
Current liability
|
$
|
(.5
|
)
|
|
$
|
(.7
|
)
|
Non-current liability
|
(6.6
|
)
|
|
(6.5
|
)
|
||
Net Amount Recognized
|
$
|
(7.1
|
)
|
|
$
|
(7.2
|
)
|
|
2014
|
|
2013
|
||||
|
(Dollars in millions)
|
||||||
Net actuarial gain
|
$
|
15.2
|
|
|
$
|
17.4
|
|
Prior service credit
|
$
|
.1
|
|
|
$
|
.4
|
|
Net Periodic Benefit Cost
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Net Periodic Benefit Cost (Income)
|
|
|
|
|
|
||||||
Service costs for benefits earned
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Interest costs on benefit obligation
|
.3
|
|
|
.3
|
|
|
.4
|
|
|||
Assumed return on plan assets
|
—
|
|
|
—
|
|
|
—
|
|
|||
Amortization of prior service credits
|
(.3
|
)
|
|
(.3
|
)
|
|
(.3
|
)
|
|||
Amortization of net gain
|
(1.4
|
)
|
|
(1.4
|
)
|
|
(1.6
|
)
|
|||
Total
|
$
|
(1.4
|
)
|
|
$
|
(1.4
|
)
|
|
$
|
(1.5
|
)
|
|
Benefit
Payments
|
|
Medicare
Part D
Subsidy
|
||||
|
(Dollars in millions)
|
||||||
2015
|
$
|
.7
|
|
|
$
|
.1
|
|
2016
|
$
|
.7
|
|
|
$
|
.1
|
|
2017
|
$
|
.7
|
|
|
$
|
.1
|
|
2018
|
$
|
.6
|
|
|
$
|
.1
|
|
2019
|
$
|
.6
|
|
|
$
|
.1
|
|
2020-2024
|
$
|
2.8
|
|
|
$
|
.5
|
|
|
2014
|
|
2013
|
|
2012
|
|||
Weighted Average Assumptions
|
|
|
|
|
|
|||
Discount rate used for liability determination
|
3.85
|
%
|
|
4.39
|
%
|
|
3.73
|
%
|
Discount rate used for expense determination
|
4.4
|
%
|
|
3.7
|
%
|
|
5.2
|
%
|
Current trend rate for health care costs
|
7.4
|
%
|
|
7.6
|
%
|
|
7.8
|
%
|
Ultimate trend rate for health care costs
|
4.5
|
%
|
|
4.5
|
%
|
|
4.5
|
%
|
Year reached
|
2028
|
|
|
2028
|
|
|
2028
|
|
Measurement date
|
11/30
|
|
|
11/30
|
|
|
11/30
|
|
|
2014
|
|
2013
|
|
2012
|
|||||||||||||||
|
Shares
|
|
Weighted
Average Exercise Price |
|
Shares
|
|
Weighted
Average Exercise Price |
|
Shares
|
|
Weighted
Average Exercise Price |
|||||||||
Outstanding at beginning of year
|
78,250
|
|
|
$
|
5.60
|
|
|
128,000
|
|
|
$
|
4.99
|
|
|
1,147,426
|
|
|
$
|
6.10
|
|
Forfeited or expired
|
(6,500
|
)
|
|
$
|
5.21
|
|
|
(20,250
|
)
|
|
$
|
4.03
|
|
|
(527,801
|
)
|
|
$
|
8.19
|
|
Exercised
|
(62,500
|
)
|
|
$
|
5.71
|
|
|
(29,500
|
)
|
|
$
|
4.04
|
|
|
(491,625
|
)
|
|
$
|
4.14
|
|
Outstanding at end of year
|
9,250
|
|
|
$
|
5.15
|
|
|
78,250
|
|
|
$
|
5.60
|
|
|
128,000
|
|
|
$
|
4.99
|
|
|
Outstanding Options
|
|
Exercisable Options
|
||||||||||
|
Number
|
|
Weighted
Average Exercise Price |
|
Weighted
Average Remaining Contractual Life (yrs) |
|
Number
|
|
Weighted
Average Exercise Price |
||||
$0.00—$4.99
|
6,250
|
|
$
|
4.70
|
|
|
0.33
|
|
6,250
|
|
$
|
4.70
|
|
$6.00—$6.99
|
3,000
|
|
$
|
6.08
|
|
|
1.7
|
|
3,000
|
|
$
|
6.08
|
|
Total
|
9,250
|
|
$
|
5.15
|
|
|
0.8
|
|
9,250
|
|
$
|
5.15
|
|
|
2014
|
|
2013
|
|
2012
|
||||||||||||
|
Shares
|
|
Weighted
Average Grant Date Fair Value |
|
Shares
|
|
Weighted
Average Grant Date Fair Value |
|
Shares
|
|
Weighted
Average Grant Date Fair Value |
||||||
Non-vested
|
956,076
|
|
$
|
7.03
|
|
|
863,150
|
|
$
|
6.86
|
|
|
1,076,475
|
|
$
|
4.99
|
|
Granted
|
341,350
|
|
$
|
9.31
|
|
|
330,850
|
|
$
|
7.87
|
|
|
385,700
|
|
$
|
5.73
|
|
Vested
|
(332,776)
|
|
$
|
7.60
|
|
|
(229,874)
|
|
$
|
7.57
|
|
|
(594,375)
|
|
$
|
2.75
|
|
Forfeited
|
(44,700)
|
|
$
|
7.91
|
|
|
(8,050)
|
|
$
|
7.51
|
|
|
(4,650)
|
|
$
|
5.94
|
|
Non-vested at end of year
|
919,950
|
|
$
|
7.63
|
|
|
956,076
|
|
$
|
7.03
|
|
|
863,150
|
|
$
|
6.86
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Net Sales
|
|
|
|
|
|
||||||
Performance Chemicals
|
|
|
|
|
|
||||||
Performance Materials
|
$
|
316.5
|
|
|
$
|
338.6
|
|
|
$
|
422.5
|
|
Specialty Chemicals
|
430.0
|
|
|
434.4
|
|
|
442.0
|
|
|||
Total Performance Chemicals
|
$
|
746.5
|
|
|
$
|
773.0
|
|
|
$
|
864.5
|
|
Engineered Surfaces
|
|
|
|
|
|
||||||
Coated Fabrics
|
$
|
98.4
|
|
|
$
|
108.9
|
|
|
$
|
117.0
|
|
Laminates and Performance Films
|
142.7
|
|
|
136.2
|
|
|
144.0
|
|
|||
Total Engineered Surfaces
|
$
|
241.1
|
|
|
$
|
245.1
|
|
|
$
|
261.0
|
|
Inter-segment sales
|
(.2
|
)
|
|
—
|
|
|
—
|
|
|||
Total Net Sales
|
$
|
987.4
|
|
|
$
|
1,018.1
|
|
|
$
|
1,125.5
|
|
Segment Operating Profit
|
|
|
|
|
|
||||||
Performance Chemicals
|
$
|
46.2
|
|
|
$
|
64.1
|
|
|
$
|
89.6
|
|
Engineered Surfaces
|
19.2
|
|
|
15.6
|
|
|
3.8
|
|
|||
Total segment operating profit
|
65.4
|
|
|
79.7
|
|
|
93.4
|
|
|||
Interest expense
|
(32.9
|
)
|
|
(31.9
|
)
|
|
(36.5
|
)
|
|||
Corporate expenses
|
(20.0
|
)
|
|
(19.8
|
)
|
|
(20.0
|
)
|
|||
Debt issuance costs write-off
|
(.8
|
)
|
|
(1.5
|
)
|
|
—
|
|
|||
Income From Continuing Operations Before Income Taxes
|
$
|
11.7
|
|
|
$
|
26.5
|
|
|
$
|
36.9
|
|
Total Assets
|
|
|
|
|
|
||||||
Performance Chemicals
|
$
|
535.8
|
|
|
$
|
547.6
|
|
|
$
|
542.6
|
|
Engineered Surfaces
|
170.9
|
|
|
129.4
|
|
|
136.6
|
|
|||
Corporate
|
122.5
|
|
|
177.7
|
|
|
194.5
|
|
|||
|
$
|
829.2
|
|
|
$
|
854.7
|
|
|
$
|
873.7
|
|
Capital Expenditures
|
|
|
|
|
|
||||||
Performance Chemicals
|
$
|
21.8
|
|
|
$
|
22.8
|
|
|
$
|
24.4
|
|
Engineered Surfaces
|
6.6
|
|
|
5.1
|
|
|
7.0
|
|
|||
Corporate
|
1.4
|
|
|
1.0
|
|
|
1.4
|
|
|||
|
$
|
29.8
|
|
|
$
|
28.9
|
|
|
$
|
32.8
|
|
Depreciation and Amortization
|
|
|
|
|
|
||||||
Performance Chemicals
|
$
|
28.1
|
|
|
$
|
26.3
|
|
|
$
|
24.1
|
|
Engineered Surfaces
|
6.2
|
|
|
7.0
|
|
|
7.6
|
|
|||
Corporate
|
.5
|
|
|
.3
|
|
|
.3
|
|
|||
|
$
|
34.8
|
|
|
$
|
33.6
|
|
|
$
|
32.0
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
(Dollars in millions)
|
||||||||||
Net Sales
|
|
|
|
|
|
||||||
United States
|
$
|
578.2
|
|
|
$
|
592.2
|
|
|
$
|
684.9
|
|
United States export sales
|
3.2
|
|
|
4.8
|
|
|
8.0
|
|
|||
Europe
|
208.9
|
|
|
216.5
|
|
|
226.8
|
|
|||
Asia
|
197.1
|
|
|
204.6
|
|
|
205.8
|
|
|||
|
$
|
987.4
|
|
|
$
|
1,018.1
|
|
|
$
|
1,125.5
|
|
Segment Operating Profit
|
|
|
|
|
|
||||||
United States
|
$
|
43.4
|
|
|
$
|
54.7
|
|
|
$
|
68.1
|
|
Europe
|
14.5
|
|
|
8.6
|
|
|
16.5
|
|
|||
Asia
|
7.5
|
|
|
16.4
|
|
|
8.8
|
|
|||
|
$
|
65.4
|
|
|
$
|
79.7
|
|
|
$
|
93.4
|
|
Total Assets
|
|
|
|
|
|
||||||
United States
|
$
|
397.4
|
|
|
$
|
408.5
|
|
|
$
|
389.6
|
|
Europe
|
285.0
|
|
|
290.3
|
|
|
296.5
|
|
|||
Asia
|
146.8
|
|
|
155.9
|
|
|
187.6
|
|
|||
|
$
|
829.2
|
|
|
$
|
854.7
|
|
|
$
|
873.7
|
|
Long-Lived Assets
|
|
|
|
|
|
||||||
United States
|
$
|
128.3
|
|
|
$
|
110.0
|
|
|
$
|
110.1
|
|
Europe
|
56.0
|
|
|
61.1
|
|
|
56.9
|
|
|||
Asia
|
54.1
|
|
|
55.4
|
|
|
55.8
|
|
|||
|
$
|
238.4
|
|
|
$
|
226.5
|
|
|
$
|
222.8
|
|
(Dollars in millions)
|
OMNOVA
Solutions
(Parent)
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Total
|
||||||||||
Net Sales
|
$
|
644.2
|
|
|
$
|
—
|
|
|
$
|
377.5
|
|
|
$
|
(34.3
|
)
|
|
$
|
987.4
|
|
Cost of products sold
|
521.2
|
|
|
—
|
|
|
300.9
|
|
|
(34.1
|
)
|
|
788.0
|
|
|||||
Gross profit
|
123.0
|
|
|
—
|
|
|
76.6
|
|
|
(.2
|
)
|
|
199.4
|
|
|||||
Selling, general and administrative
|
80.5
|
|
|
—
|
|
|
39.7
|
|
|
—
|
|
|
120.2
|
|
|||||
Depreciation and amortization
|
19.8
|
|
|
—
|
|
|
15.0
|
|
|
—
|
|
|
34.8
|
|
|||||
Gain on sale of assets
|
.2
|
|
|
—
|
|
|
.3
|
|
|
—
|
|
|
.5
|
|
|||||
Restructuring and severance
|
.8
|
|
|
—
|
|
|
.1
|
|
|
—
|
|
|
.9
|
|
|||||
Interest expense
|
29.6
|
|
|
(1.3
|
)
|
|
4.6
|
|
|
—
|
|
|
32.9
|
|
|||||
Debt issuance cost write-off
|
.8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
.8
|
|
|||||
(Income) loss from subsidiaries
|
(20.6
|
)
|
|
(8.8
|
)
|
|
—
|
|
|
29.4
|
|
|
—
|
|
|||||
Other (income) expense, net
|
(5.8
|
)
|
|
.1
|
|
|
3.5
|
|
|
(.2
|
)
|
|
(2.4
|
)
|
|||||
Total costs and other expenses
|
105.3
|
|
|
(10.0
|
)
|
|
63.2
|
|
|
29.2
|
|
|
187.7
|
|
|||||
Income (loss) from continuing operations before income taxes
|
17.7
|
|
|
10.0
|
|
|
13.4
|
|
|
(29.4
|
)
|
|
11.7
|
|
|||||
Income tax expense (benefit)
|
5.6
|
|
|
(10.7
|
)
|
|
4.7
|
|
|
—
|
|
|
(.4
|
)
|
|||||
Income (loss) from continuing operations
|
12.1
|
|
|
20.7
|
|
|
8.7
|
|
|
(29.4
|
)
|
|
12.1
|
|
|||||
Loss from discontinued operations
|
(.6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(.6
|
)
|
|||||
Net Income (Loss)
|
$
|
11.5
|
|
|
$
|
20.7
|
|
|
$
|
8.7
|
|
|
$
|
(29.4
|
)
|
|
$
|
11.5
|
|
(Dollars in millions)
|
OMNOVA
Solutions
(Parent)
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Total
|
||||||||||
Net Sales
|
$
|
658.1
|
|
|
$
|
—
|
|
|
$
|
392.6
|
|
|
$
|
(32.6
|
)
|
|
$
|
1,018.1
|
|
Cost of products sold
|
522.9
|
|
|
—
|
|
|
314.5
|
|
|
(32.0
|
)
|
|
805.4
|
|
|||||
Gross profit
|
135.2
|
|
|
—
|
|
|
78.1
|
|
|
(.6
|
)
|
|
212.7
|
|
|||||
Selling, general and administrative
|
82.1
|
|
|
—
|
|
|
36.0
|
|
|
—
|
|
|
118.1
|
|
|||||
Depreciation and amortization
|
17.8
|
|
|
—
|
|
|
15.8
|
|
|
—
|
|
|
33.6
|
|
|||||
Gain on sale of assets
|
(1.8
|
)
|
|
—
|
|
|
(3.1
|
)
|
|
—
|
|
|
(4.9
|
)
|
|||||
Restructuring and severance
|
4.6
|
|
|
—
|
|
|
2.5
|
|
|
—
|
|
|
7.1
|
|
|||||
Asset impairment
|
.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
.2
|
|
|||||
Interest expense
|
24.0
|
|
|
—
|
|
|
7.9
|
|
|
—
|
|
|
31.9
|
|
|||||
Debt issuance cost write-off
|
1.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.5
|
|
|||||
(Income) loss from subsidiaries
|
(9.6
|
)
|
|
(13.4
|
)
|
|
—
|
|
|
23.0
|
|
|
—
|
|
|||||
Other (income) expense, net
|
(6.5
|
)
|
|
(.3
|
)
|
|
5.4
|
|
|
.1
|
|
|
(1.3
|
)
|
|||||
Total costs and other expenses
|
112.3
|
|
|
(13.7
|
)
|
|
64.5
|
|
|
23.1
|
|
|
186.2
|
|
|||||
Income (loss) from continuing operations before income taxes
|
22.9
|
|
|
13.7
|
|
|
13.6
|
|
|
(23.7
|
)
|
|
26.5
|
|
|||||
Income tax expense
|
2.4
|
|
|
3.4
|
|
|
.2
|
|
|
—
|
|
|
6.0
|
|
|||||
Income (loss) from continuing operations
|
20.5
|
|
|
10.3
|
|
|
13.4
|
|
|
(23.7
|
)
|
|
20.5
|
|
|||||
Loss from discontinued operations
|
(.9
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(.9
|
)
|
|||||
Net Income (Loss)
|
$
|
19.6
|
|
|
$
|
10.3
|
|
|
$
|
13.4
|
|
|
$
|
(23.7
|
)
|
|
$
|
19.6
|
|
(Dollars in millions)
|
OMNOVA
Solutions
(Parent)
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Total
|
||||||||||
Net Sales
|
$
|
749.7
|
|
|
$
|
—
|
|
|
$
|
407.7
|
|
|
$
|
(31.9
|
)
|
|
$
|
1,125.5
|
|
Cost of products sold
|
601.2
|
|
|
—
|
|
|
328.5
|
|
|
(31.4
|
)
|
|
898.3
|
|
|||||
Gross profit
|
148.5
|
|
|
—
|
|
|
79.2
|
|
|
(.5
|
)
|
|
227.2
|
|
|||||
Selling, general and administrative
|
84.0
|
|
|
.9
|
|
|
36.3
|
|
|
—
|
|
|
121.2
|
|
|||||
Depreciation and amortization
|
16.2
|
|
|
—
|
|
|
15.8
|
|
|
—
|
|
|
32.0
|
|
|||||
Restructuring and severance
|
1.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.0
|
|
|||||
Asset impairment
|
.8
|
|
|
—
|
|
|
.2
|
|
|
—
|
|
|
1.0
|
|
|||||
Interest expense
|
29.8
|
|
|
(1.9
|
)
|
|
8.8
|
|
|
(.2
|
)
|
|
36.5
|
|
|||||
Deferred financing fees write-off
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
(Income) loss from subsidiaries
|
(5.6
|
)
|
|
(8.3
|
)
|
|
—
|
|
|
13.9
|
|
|
—
|
|
|||||
Other (income) expense, net
|
(3.7
|
)
|
|
(.8
|
)
|
|
2.9
|
|
|
.2
|
|
|
(1.4
|
)
|
|||||
Total costs and other expenses
|
122.5
|
|
|
(10.1
|
)
|
|
64.0
|
|
|
13.9
|
|
|
190.3
|
|
|||||
Income (loss) from continuing operations before income taxes
|
26.0
|
|
|
10.1
|
|
|
15.2
|
|
|
(14.4
|
)
|
|
36.9
|
|
|||||
Income tax expense
|
3.3
|
|
|
3.1
|
|
|
4.8
|
|
|
—
|
|
|
11.2
|
|
|||||
Income (loss) from continuing operations
|
22.7
|
|
|
7.0
|
|
|
10.4
|
|
|
(14.4
|
)
|
|
25.7
|
|
|||||
Income (loss) from discontinued operations
|
4.9
|
|
|
(.9
|
)
|
|
(2.1
|
)
|
|
—
|
|
|
1.9
|
|
|||||
Net Income (Loss)
|
$
|
27.6
|
|
|
$
|
6.1
|
|
|
$
|
8.3
|
|
|
$
|
(14.4
|
)
|
|
$
|
27.6
|
|
Condensed Consolidating Statements of Comprehensive Income (Loss) for Year Ended November 30, 2013
|
||||||||||||||||||||
(Dollars in millions)
|
|
OMNOVA Solutions (Parent)
|
|
Guarantor Subsidiaries
|
|
Non - Guarantor Subsidiaries
|
|
Eliminations
|
|
Total
|
||||||||||
Net Income (loss)
|
|
$
|
19.6
|
|
|
$
|
10.3
|
|
|
$
|
13.4
|
|
|
$
|
(23.7
|
)
|
|
$
|
19.6
|
|
Other comprehensive income (loss), net of tax
|
|
26.1
|
|
|
18.5
|
|
|
5.1
|
|
|
(23.6
|
)
|
|
26.1
|
|
|||||
Comprehensive income (loss)
|
|
$
|
45.7
|
|
|
$
|
28.8
|
|
|
$
|
18.5
|
|
|
$
|
(47.3
|
)
|
|
$
|
45.7
|
|
(Dollars in millions)
|
OMNOVA
Solutions
(Parent)
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Total
|
||||||||||
ASSETS:
|
|
|
|
|
|
|
|
|
|
||||||||||
Current Assets
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
$
|
43.9
|
|
|
$
|
—
|
|
|
$
|
55.6
|
|
|
$
|
—
|
|
|
$
|
99.5
|
|
Accounts receivable, net
|
68.9
|
|
|
—
|
|
|
66.8
|
|
|
—
|
|
|
135.7
|
|
|||||
Inventories
|
51.9
|
|
|
—
|
|
|
42.6
|
|
|
(1.8
|
)
|
|
92.7
|
|
|||||
Deferred income taxes
|
5.0
|
|
|
—
|
|
|
2.1
|
|
|
(.1
|
)
|
|
7.0
|
|
|||||
Prepaid expenses and other
|
4.9
|
|
|
6.9
|
|
|
8.8
|
|
|
.4
|
|
|
21.0
|
|
|||||
Total Current Assets
|
174.6
|
|
|
6.9
|
|
|
175.9
|
|
|
(1.5
|
)
|
|
355.9
|
|
|||||
Property, plant and equipment, net
|
128.3
|
|
|
—
|
|
|
110.1
|
|
|
—
|
|
|
238.4
|
|
|||||
Goodwill and other intangible assets, net
|
75.9
|
|
|
—
|
|
|
75.9
|
|
|
—
|
|
|
151.8
|
|
|||||
Deferred income taxes
|
65.4
|
|
|
.5
|
|
|
8.8
|
|
|
(6.5
|
)
|
|
68.2
|
|
|||||
Intercompany
|
351.9
|
|
|
52.6
|
|
|
152.9
|
|
|
(557.4
|
)
|
|
—
|
|
|||||
Investments in subsidiaries
|
111.3
|
|
|
144.2
|
|
|
—
|
|
|
(255.5
|
)
|
|
—
|
|
|||||
Deferred financing fees
|
7.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7.0
|
|
|||||
Other assets
|
2.5
|
|
|
3.8
|
|
|
1.6
|
|
|
—
|
|
|
7.9
|
|
|||||
Total Assets
|
$
|
916.9
|
|
|
$
|
208.0
|
|
|
$
|
525.2
|
|
|
$
|
(820.9
|
)
|
|
$
|
829.2
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY:
|
|
|
|
|
|
|
|
|
|
||||||||||
Current Liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
Amounts due to banks
|
$
|
2.4
|
|
|
$
|
—
|
|
|
$
|
3.2
|
|
|
$
|
—
|
|
|
$
|
5.6
|
|
Accounts payable
|
43.0
|
|
|
—
|
|
|
51.3
|
|
|
—
|
|
|
94.3
|
|
|||||
Accrued payroll and personal property taxes
|
10.3
|
|
|
.1
|
|
|
7.4
|
|
|
—
|
|
|
17.8
|
|
|||||
Employee benefit obligations
|
2.9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.9
|
|
|||||
Accrued interest
|
1.4
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.4
|
|
|||||
Deferred income taxes
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Other current liabilities
|
6.1
|
|
|
—
|
|
|
—
|
|
|
(4.3
|
)
|
|
1.8
|
|
|||||
Total Current Liabilities
|
66.1
|
|
|
.1
|
|
|
61.9
|
|
|
(4.3
|
)
|
|
123.8
|
|
|||||
Long-term debt
|
406.4
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
406.4
|
|
|||||
Postretirement benefits other than pensions
|
6.6
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6.6
|
|
|||||
Pension liabilities
|
98.7
|
|
|
—
|
|
|
12.1
|
|
|
—
|
|
|
110.8
|
|
|||||
Deferred income taxes
|
—
|
|
|
—
|
|
|
28.0
|
|
|
(6.4
|
)
|
|
21.6
|
|
|||||
Intercompany
|
181.6
|
|
|
114.1
|
|
|
267.8
|
|
|
(563.5
|
)
|
|
—
|
|
|||||
Other liabilities
|
7.0
|
|
|
—
|
|
|
2.5
|
|
|
—
|
|
|
9.5
|
|
|||||
Total Liabilities
|
766.4
|
|
|
114.2
|
|
|
372.3
|
|
|
(574.2
|
)
|
|
678.7
|
|
|||||
Total Shareholders’ Equity
|
150.5
|
|
|
93.8
|
|
|
152.9
|
|
|
(246.7
|
)
|
|
150.5
|
|
|||||
Total Liabilities and Shareholders’ Equity
|
$
|
916.9
|
|
|
$
|
208.0
|
|
|
$
|
525.2
|
|
|
$
|
(820.9
|
)
|
|
$
|
829.2
|
|
(Dollars in millions)
|
OMNOVA
Solutions
(Parent)
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Total
|
||||||||||
ASSETS:
|
|
|
|
|
|
|
|
|
|
||||||||||
Current Assets
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
$
|
102.1
|
|
|
$
|
—
|
|
|
$
|
62.8
|
|
|
$
|
—
|
|
|
$
|
164.9
|
|
Accounts receivable, net
|
56.9
|
|
|
—
|
|
|
66.2
|
|
|
—
|
|
|
123.1
|
|
|||||
Inventories
|
45.6
|
|
|
—
|
|
|
44.1
|
|
|
(1.6
|
)
|
|
88.1
|
|
|||||
Deferred income taxes
|
6.2
|
|
|
—
|
|
|
2.8
|
|
|
(.6
|
)
|
|
8.4
|
|
|||||
Prepaid expenses and other
|
6.8
|
|
|
—
|
|
|
10.3
|
|
|
.5
|
|
|
17.6
|
|
|||||
Total Current Assets
|
217.6
|
|
|
—
|
|
|
186.2
|
|
|
(1.7
|
)
|
|
402.1
|
|
|||||
Property, plant and equipment, net
|
110.1
|
|
|
—
|
|
|
116.4
|
|
|
—
|
|
|
226.5
|
|
|||||
Goodwill and other intangible assets, net
|
76.9
|
|
|
—
|
|
|
85.6
|
|
|
—
|
|
|
162.5
|
|
|||||
Deferred income taxes
|
46.9
|
|
|
—
|
|
|
7.1
|
|
|
(7.1
|
)
|
|
46.9
|
|
|||||
Intercompany
|
386.0
|
|
|
14.6
|
|
|
164.3
|
|
|
(564.9
|
)
|
|
—
|
|
|||||
Investments in subsidiaries
|
134.0
|
|
|
194.6
|
|
|
—
|
|
|
(328.6
|
)
|
|
—
|
|
|||||
Deferred financing fees
|
9.3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9.3
|
|
|||||
Other assets
|
2.7
|
|
|
3.8
|
|
|
.9
|
|
|
—
|
|
|
7.4
|
|
|||||
Total Assets
|
$
|
983.5
|
|
|
$
|
213.0
|
|
|
$
|
560.5
|
|
|
$
|
(902.3
|
)
|
|
$
|
854.7
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY:
|
|
|
|
|
|
|
|
|
|
||||||||||
Current Liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
Amounts due to banks
|
$
|
2.0
|
|
|
$
|
—
|
|
|
$
|
2.6
|
|
|
$
|
—
|
|
|
$
|
4.6
|
|
Accounts payable
|
38.4
|
|
|
—
|
|
|
53.5
|
|
|
.2
|
|
|
92.1
|
|
|||||
Accrued payroll and personal property taxes
|
14.5
|
|
|
—
|
|
|
5.9
|
|
|
—
|
|
|
20.4
|
|
|||||
Employee benefit obligations
|
2.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.1
|
|
|||||
Accrued interest
|
1.7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1.7
|
|
|||||
Deferred income taxes
|
—
|
|
|
—
|
|
|
.6
|
|
|
(.6
|
)
|
|
—
|
|
|||||
Other current liabilities
|
7.5
|
|
|
.2
|
|
|
—
|
|
|
(1.9
|
)
|
|
5.8
|
|
|||||
Total Current Liabilities
|
66.2
|
|
|
.2
|
|
|
62.6
|
|
|
(2.3
|
)
|
|
126.7
|
|
|||||
Long-term debt
|
444.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
444.0
|
|
|||||
Postretirement benefits other than pensions
|
6.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6.5
|
|
|||||
Pension liabilities
|
55.2
|
|
|
—
|
|
|
12.0
|
|
|
—
|
|
|
67.2
|
|
|||||
Deferred income taxes
|
—
|
|
|
—
|
|
|
30.4
|
|
|
(7.1
|
)
|
|
23.3
|
|
|||||
Intercompany
|
226.1
|
|
|
84.2
|
|
|
259.4
|
|
|
(569.7
|
)
|
|
—
|
|
|||||
Other liabilities
|
7.5
|
|
|
—
|
|
|
1.5
|
|
|
—
|
|
|
9.0
|
|
|||||
Total Liabilities
|
805.5
|
|
|
84.4
|
|
|
365.9
|
|
|
(579.1
|
)
|
|
676.7
|
|
|||||
Shareholders’ Equity
|
178.0
|
|
|
128.6
|
|
|
194.6
|
|
|
(323.2
|
)
|
|
178.0
|
|
|||||
Total Liabilities and Shareholders’ Equity
|
$
|
983.5
|
|
|
$
|
213.0
|
|
|
$
|
560.5
|
|
|
$
|
(902.3
|
)
|
|
$
|
854.7
|
|
(Dollars in millions)
|
OMNOVA
Solutions
(Parent)
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Total
|
||||||||||
Operating Activities
|
|
|
|
|
|
|
|
|
|
||||||||||
Net Cash (Used In) Provided By Operating Activities
|
$
|
(2.6
|
)
|
|
$
|
.1
|
|
|
$
|
5.0
|
|
|
$
|
12.5
|
|
|
$
|
15.0
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
||||||||||
Capital expenditures
|
(20.4
|
)
|
|
—
|
|
|
(9.4
|
)
|
|
—
|
|
|
(29.8
|
)
|
|||||
Proceeds from note receivable
|
2.3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.3
|
|
|||||
Proceeds from insurance settlements
|
—
|
|
|
—
|
|
|
2.4
|
|
|
—
|
|
|
2.4
|
|
|||||
Acquisitions of business, less cash received
|
—
|
|
|
19.7
|
|
|
—
|
|
|
(19.7
|
)
|
|
—
|
|
|||||
Proceeds from asset disposals
|
—
|
|
|
13.0
|
|
|
(37.8
|
)
|
|
24.8
|
|
|
—
|
|
|||||
Investment in subsidiaries and other
|
—
|
|
|
—
|
|
|
—
|
|
|
.1
|
|
|
.1
|
|
|||||
Net Cash (Used in) Provided by Investing Activities
|
(18.1
|
)
|
|
32.7
|
|
|
(44.8
|
)
|
|
5.2
|
|
|
(25.0
|
)
|
|||||
Proceeds from borrowings
|
15.3
|
|
|
(31.9
|
)
|
|
16.6
|
|
|
—
|
|
|
—
|
|
|||||
Repayment of debt obligations
|
(52.0
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(52.0
|
)
|
|||||
Short-term debt borrowings
|
—
|
|
|
—
|
|
|
23.3
|
|
|
—
|
|
|
23.3
|
|
|||||
Short-term debt payments
|
—
|
|
|
—
|
|
|
(22.7
|
)
|
|
—
|
|
|
(22.7
|
)
|
|||||
Cash received from exercise of stock options
|
.3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
.3
|
|
|||||
Purchase of treasury shares
|
(1.4
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1.4
|
)
|
|||||
Net Cash (Used in) Provided by Financing Activities
|
(37.8
|
)
|
|
(31.9
|
)
|
|
17.2
|
|
|
—
|
|
|
(52.5
|
)
|
|||||
Effect of exchange rate changes on cash
|
.3
|
|
|
(.9
|
)
|
|
15.4
|
|
|
(17.7
|
)
|
|
(2.9
|
)
|
|||||
Net Increase (Decrease) in Cash and Cash Equivalents
|
(58.2
|
)
|
|
—
|
|
|
(7.2
|
)
|
|
—
|
|
|
(65.4
|
)
|
|||||
Cash and cash equivalents at beginning of period
|
102.1
|
|
|
—
|
|
|
62.8
|
|
|
—
|
|
|
164.9
|
|
|||||
Cash and Cash Equivalents at End of Period
|
$
|
43.9
|
|
|
$
|
—
|
|
|
$
|
55.6
|
|
|
$
|
—
|
|
|
$
|
99.5
|
|
(Dollars in millions)
|
OMNOVA
Solutions
(Parent)
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Total
|
||||||||||
Net Cash Provided By (Used In) Operating Activities
|
$
|
29.2
|
|
|
$
|
(4.7
|
)
|
|
$
|
24.9
|
|
|
$
|
(3.6
|
)
|
|
$
|
45.8
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
||||||||||
Capital expenditures
|
(12.8
|
)
|
|
—
|
|
|
(16.1
|
)
|
|
—
|
|
|
(28.9
|
)
|
|||||
Proceeds from insurance settlements
|
—
|
|
|
—
|
|
|
.2
|
|
|
|
|
.2
|
|
||||||
Proceeds from asset sales
|
1.7
|
|
|
—
|
|
|
5.0
|
|
|
—
|
|
|
6.7
|
|
|||||
Investment in subsidiaries and other
|
(5.2
|
)
|
|
(8.5
|
)
|
|
—
|
|
|
13.7
|
|
|
—
|
|
|||||
Net Cash (Used in) Provided by Investing Activities
|
(16.3
|
)
|
|
(8.5
|
)
|
|
(10.9
|
)
|
|
13.7
|
|
|
(22.0
|
)
|
|||||
Financing Activities
|
|
|
|
|
|
|
|
|
|
||||||||||
Repayment of debt obligations
|
(2.0
|
)
|
|
—
|
|
|
(3.4
|
)
|
|
3.4
|
|
|
(2.0
|
)
|
|||||
Short-term debt borrowings
|
—
|
|
|
—
|
|
|
34.9
|
|
|
—
|
|
|
34.9
|
|
|||||
Short-term debt payments
|
—
|
|
|
—
|
|
|
(39.4
|
)
|
|
—
|
|
|
(39.4
|
)
|
|||||
Payments for debt refinancing
|
(.6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(.6
|
)
|
|||||
Restricted cash
|
5.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5.5
|
|
|||||
Cash received from exercise of stock options
|
.1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
.1
|
|
|||||
Other
|
—
|
|
|
8.5
|
|
|
8.5
|
|
|
(17.0
|
)
|
|
—
|
|
|||||
Net Cash Provided by (Used in) Financing Activities
|
3.0
|
|
|
8.5
|
|
|
.6
|
|
|
(13.6
|
)
|
|
(1.5
|
)
|
|||||
Effect of exchange rate changes on cash
|
(12.5
|
)
|
|
4.7
|
|
|
3.9
|
|
|
3.5
|
|
|
(.4
|
)
|
|||||
Net Increase in Cash and Cash Equivalents
|
3.4
|
|
|
—
|
|
|
18.5
|
|
|
—
|
|
|
21.9
|
|
|||||
Cash and cash equivalents at beginning of period
|
98.7
|
|
|
—
|
|
|
44.3
|
|
|
—
|
|
|
143.0
|
|
|||||
Cash and Cash Equivalents at End of Period
|
$
|
102.1
|
|
|
$
|
—
|
|
|
$
|
62.8
|
|
|
$
|
—
|
|
|
$
|
164.9
|
|
(Dollars in millions)
|
OMNOVA
Solutions
(Parent)
|
|
Guarantor
Subsidiaries
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Total
|
||||||||||
Net Cash Provided By (Used In) Operating Activities
|
$
|
55.2
|
|
|
$
|
3.9
|
|
|
$
|
8.0
|
|
|
$
|
(1.8
|
)
|
|
$
|
65.3
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
||||||||||
Capital expenditures
|
(20.1
|
)
|
|
—
|
|
|
(12.7
|
)
|
|
—
|
|
|
(32.8
|
)
|
|||||
Proceeds from sale of business and asset sales
|
12.7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12.7
|
|
|||||
Investment in subsidiary and other
|
(3.4
|
)
|
|
1.1
|
|
|
—
|
|
|
2.3
|
|
|
—
|
|
|||||
Net Cash (Used In) Provided by Investing Activities
|
(10.8
|
)
|
|
1.1
|
|
|
(12.7
|
)
|
|
2.3
|
|
|
(20.1
|
)
|
|||||
Financing Activities
|
|
|
|
|
|
|
|
|
|
||||||||||
Proceeds from borrowings
|
—
|
|
|
—
|
|
|
3.4
|
|
|
(3.4
|
)
|
|
—
|
|
|||||
Repayment of debt obligations
|
(2.0
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2.0
|
)
|
|||||
Short-term debt borrowings
|
—
|
|
|
—
|
|
|
43.8
|
|
|
—
|
|
|
43.8
|
|
|||||
Short-term debt payments
|
—
|
|
|
—
|
|
|
(45.4
|
)
|
|
—
|
|
|
(45.4
|
)
|
|||||
Restricted Cash
|
(1.3
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1.3
|
)
|
|||||
Cash received from exercise of stock options
|
2.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2.0
|
|
|||||
Other
|
—
|
|
|
—
|
|
|
(1.1
|
)
|
|
1.1
|
|
|
—
|
|
|||||
Net Cash (Used in) Provided by Financing Activities
|
(1.3
|
)
|
|
—
|
|
|
.7
|
|
|
(2.3
|
)
|
|
(2.9
|
)
|
|||||
Effect of exchange rate changes on cash
|
.5
|
|
|
(5.0
|
)
|
|
4.5
|
|
|
1.8
|
|
|
1.8
|
|
|||||
Net Increase in Cash and Cash Equivalents
|
43.6
|
|
|
—
|
|
|
.5
|
|
|
—
|
|
|
44.1
|
|
|||||
Cash and cash equivalents at beginning of period
|
55.1
|
|
|
—
|
|
|
43.8
|
|
|
—
|
|
|
98.9
|
|
|||||
Cash and Cash Equivalents at End of Period
|
$
|
98.7
|
|
|
$
|
—
|
|
|
$
|
44.3
|
|
|
$
|
—
|
|
|
$
|
143.0
|
|
|
Three Months Ended
|
||||||||||||||
2014
|
February 28
|
|
May 31
|
|
August 31
|
|
November 30
|
||||||||
|
(Dollars in millions, except per share amounts)
|
||||||||||||||
Net sales
|
$
|
225.9
|
|
|
$
|
266.4
|
|
|
$
|
252.1
|
|
|
$
|
243.0
|
|
Gross profit
(1)(2)
|
$
|
49.1
|
|
|
$
|
52.6
|
|
|
$
|
49.2
|
|
|
$
|
48.5
|
|
Restructuring and severance
|
$
|
.3
|
|
|
$
|
.5
|
|
|
$
|
—
|
|
|
$
|
.1
|
|
Asset sales
|
$
|
—
|
|
|
$
|
.1
|
|
|
$
|
.3
|
|
|
$
|
.1
|
|
Asset impairments and write-offs
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Debt issuance costs write-off
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
.8
|
|
Income from continuing operations
(4)
|
$
|
1.4
|
|
|
$
|
3.8
|
|
|
$
|
1.8
|
|
|
$
|
5.1
|
|
Loss from discontinued operations
|
$
|
(.2
|
)
|
|
$
|
(.4
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
Net income
(3) (4)
|
$
|
1.2
|
|
|
$
|
3.4
|
|
|
$
|
1.8
|
|
|
$
|
5.1
|
|
Income per share from continuing operations
(5)
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
.03
|
|
|
$
|
.08
|
|
|
$
|
.04
|
|
|
$
|
.11
|
|
Diluted
|
$
|
.03
|
|
|
$
|
.08
|
|
|
$
|
.04
|
|
|
$
|
.11
|
|
Net income per share
(4)
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
.03
|
|
|
$
|
.07
|
|
|
$
|
.04
|
|
|
$
|
.11
|
|
Diluted
|
$
|
.03
|
|
|
$
|
.07
|
|
|
$
|
.04
|
|
|
$
|
.11
|
|
Common stock price range per share—high
|
$
|
10.11
|
|
|
$
|
11.03
|
|
|
$
|
10.07
|
|
|
$
|
8.52
|
|
—low
|
$
|
8.13
|
|
|
$
|
8.41
|
|
|
$
|
7.80
|
|
|
$
|
5.15
|
|
|
Three Months Ended
|
||||||||||||||
2013
|
February 28
|
|
May 31
|
|
August 31
|
|
November 30
|
||||||||
|
(Dollars in millions, except per share amounts)
|
||||||||||||||
Net sales
|
$
|
251.7
|
|
|
$
|
270.8
|
|
|
$
|
261.2
|
|
|
$
|
234.4
|
|
Gross profit
(1)(2)
|
$
|
49.0
|
|
|
$
|
57.3
|
|
|
$
|
54.7
|
|
|
$
|
51.7
|
|
Restructuring and severance
|
$
|
.8
|
|
|
$
|
4.6
|
|
|
$
|
1.4
|
|
|
$
|
.3
|
|
Asset sales
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(1.8
|
)
|
|
$
|
(3.1
|
)
|
Asset impairments and write-offs
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
.2
|
|
Debt issuance costs write-off
|
$
|
—
|
|
|
$
|
1.5
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Income from continuing operations
(3)
|
$
|
.2
|
|
|
$
|
2.6
|
|
|
$
|
9.0
|
|
|
$
|
8.7
|
|
(Loss) income from discontinued operations
|
$
|
(.4
|
)
|
|
$
|
.3
|
|
|
$
|
—
|
|
|
$
|
(.8
|
)
|
Net (loss) income
|
$
|
(.2
|
)
|
|
$
|
2.9
|
|
|
$
|
9.0
|
|
|
$
|
7.9
|
|
Income per share from continuing operations
(5)
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
—
|
|
|
$
|
.06
|
|
|
$
|
.19
|
|
|
$
|
.19
|
|
Diluted
|
$
|
—
|
|
|
$
|
.06
|
|
|
$
|
.19
|
|
|
$
|
.19
|
|
Net income per share
(4)
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
—
|
|
|
$
|
.06
|
|
|
$
|
.19
|
|
|
$
|
.17
|
|
Diluted
|
$
|
—
|
|
|
$
|
.06
|
|
|
$
|
.19
|
|
|
$
|
.17
|
|
Common stock price range per share—high
|
$
|
8.54
|
|
|
$
|
8.41
|
|
|
$
|
8.68
|
|
|
$
|
9.02
|
|
—low
|
$
|
6.77
|
|
|
$
|
6.40
|
|
|
$
|
7.41
|
|
|
$
|
7.85
|
|
(1)
|
Gross profit excludes depreciation and amortization expense. Depreciation and amortization expense related to manufacturing facilities and equipment was
$5.8 million
,
$6.0 million
,
$5.8 million
, and
$5.8 million
for the three months ended February 28, 2014, May 31, 2014, August 31, 2014, and November 30, 2014, and
$5.3 million
,
$5.4 million
,
$5.6 million
, and
$5.9 million
for the three months ended February 28, 2013, May 31, 2013, August 31, 2013 and November 30, 2013, respectively.
|
(2)
|
Gross profit includes net LIFO inventory reserve adjustments of
$0.7 million
of expense,
$0.8 million
of expense,
$0.3 million
of income, and
$2.4 million
of income for the three months ended February 28, 2014, May 31, 2014, August 31, 2014, and November 30, 2014, respectively, and
$0.9 million
of income,
$3.5 million
of income, and
$1.8 million
of income for the three months ended May 31, 2013, August 31, 2013, and November 30, 2013, respectively.
|
(3)
|
Income from continuing operations and net income for the three months ended November 30, 2014 includes
$6.9 million
for the reversal of a valuation allowance related to capital loss carryforwards in the U.S. The three months ended November 30, 2013 includes
$1.5 million
of tax benefits from sold operations and
$1.0 million
of benefits related to tax audit settlements in foreign jurisdictions.
|
(4)
|
Income from continuing operations and net income for the three months ended November 30, 2014 includes
$2.0 million
of debt redemption premium expense related to early debt redemption.
|
(5)
|
The sum of the quarterly earnings per share amounts may not equal the annual amount due to changes in the number of shares outstanding during the year.
|
Item 9.
|
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
Item 9A.
|
|
Controls and Procedures
|
Item 9B.
|
|
Other Information
|
Item 10.
|
|
Directors and Executive Officers of the Registrant
|
Item 11.
|
|
Executive Compensation
|
Item 12.
|
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
Plan Category
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
|
Weighted average exercise price of outstanding options, warrants and rights
|
|
Number of securities remaining available for issuance under equity compensation plans
|
Equity compensation plans approved by security holders
|
929,200
|
|
$5.15
|
|
2,537,927
|
Equity compensation plans not approved by security holders
|
N/A
|
|
N/A
|
|
N/A
|
Total
|
929,200
|
|
$5.15
|
|
2,537,927
|
Item 13.
|
|
Certain Relationships and Related Transactions, Director Independence
|
Item 14.
|
|
Principal Accountant Fees and Services
|
Item 15.
|
|
Exhibits and Financial Statement Schedules
|
Exhibit
|
|
Description
|
|
|
ACQUISITION AGREEMENTS
|
2.1
|
|
Sale and Purchase Agreement among OMNOVA Solutions Inc., AXA LBO Fund III-A, AXA LBO Fund III-B and the other holders of equity securities of Eliokem International SAS (incorporated by reference to the same numbered exhibit to the Company’s Current Report on Form 8-K filed November 24, 2010 (File No. 1-15147)).
|
|
|
|
|
|
CHARTER DOCUMENTS
|
3.2**
|
|
Form of Amended and Restated Articles of Incorporation of OMNOVA Solutions Inc.
|
3.3
|
|
Amended and Restated Articles of Incorporation of OMNOVA Solutions Inc.
|
3.4**
|
|
Amended and Restated Code of Regulations of OMNOVA Solutions Inc.
|
|
|
|
|
|
INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS
|
4.1
|
|
Indenture dated as of November 3, 2010 by and among OMNOVA Solutions Inc., the Guarantors (as defined therein) and Wells Fargo Bank, National Association, as trustee (incorporated by reference to the same numbered exhibit to the Company’s Current Report on Form 8-K filed November 4, 2010 (File No. 1-15147)).
|
|
|
|
Exhibit
|
|
Description
|
|
|
|
|
|
MATERIAL CONTRACTS
|
10.3†
|
|
Amended and Restated Employment Agreement dated December 31, 2009 between OMNOVA Solutions and Kevin M. McMullen (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).
|
10.5†
|
|
Amended and Restated Severance Agreement dated December 31, 2009 between OMNOVA Solutions and Kevin M. McMullen (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).
|
10.6†
|
|
Form of Amended and Restated Severance Agreement granted to certain executive officers of OMNOVA Solutions (other than the officer identified above) (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).
|
10.7†
|
|
OMNOVA Solutions Third Amended and Restated 1999 Equity and Performance Incentive Plan, (incorporated by reference to Appendix C to the Company's 2012 Proxy Statement filed with the Securities and Exchange Commission on February 3, 2012 (File No. 1-15147).
|
10.8†
|
|
OMNOVA Solutions Deferred Compensation Plan for Nonemployee Directors, as amended and restated effective January 1, 2009 (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).
|
10.9†
|
|
Retirement Plan for Nonemployee Directors of OMNOVA Solutions, as amended and restated effective January 1, 2009 (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).
|
10.11†
|
|
Savings Benefits Restoration Plan for Salaried Employees of OMNOVA Solutions (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).
|
10.12†
|
|
Pension Benefits Restoration Plan for Salaried Employees of OMNOVA Solutions (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).
|
10.13
|
|
OMNOVA Solutions Corporate Officers Severance Plan, effective January 1, 2009 (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2008 (File No. 1-15147)).
|
10.14†
|
|
OMNOVA Solutions Long-Term Incentive Program, as amended and restated effective January 19, 2012 (incorporated by reference to Appendix B to the Company’s 2012 Proxy Statement filed with the Securities and Exchange Commission on February 3, 2012 (File No. 1-15147)).
|
10.22†
|
|
Form of Deferred Share Agreement (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2009 (File No. 1-15147)).
|
10.23†
|
|
Form of Performance Share Agreement (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2012 (File No. 1-15147)).
|
10.24†
|
|
Form of Restricted Stock Agreement (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2011 (File No. 1-15147)).
|
10.26†
|
|
OMNOVA Solutions Executive Incentive Compensation, as amended and restated effective January 19, 2012 (incorporated by reference to Appendix A to the Company’s 2012 Proxy Statement filed with the Securities and Exchange Commission on February 3, 2012 (File No. 1-15147)).
|
10.30
|
|
Second Amended and Restated Term Loan Credit Agreement dated as of December 9, 2010 by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto as Lenders, and Deutsche Bank Trust Company Americas, as agent for the Lenders (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2010 (File No. 1-15147)).
|
10.32
|
|
Second Amended and Restated Senior Secured Credit Facility dated as of December 9, 2010 by and among OMNOVA Solutions Inc. and ELIOKEM Inc., as borrowers, the financial institutions party thereto, as Lenders, and JPMorgan Chase Bank N.A., as agent for the Lenders (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2010 (File No. 1-15147)).
|
10.33
|
|
Amendment dated March 7, 2013, to Second Amended and Restated Term Loan Credit Agreement dated as of December 9, 2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders, and Deutsche Bank Trust Company Americas, as agent for the Lenders (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2013 (File No. 1-15147)).
|
10.34
|
|
Amendment dated April 5, 2013, to Second Amended and Restated Credit Agreement dated as of December 9, 2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders, and JP Morgan Chase Bank, N.A., as agent for the Lenders (incorporated by reference to the same numbered exhibit to the Company’s Annual Report on Form 10-K for the year ended November 30, 2010 (File No. 1-15147)).
|
10.35
|
|
Amendment No. 2, dated March 28, 2014, to Second Amended and Restated Term Loan Credit Agreement dated as of December 9, 2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders, and Deutsche Bank Trust Company Americas, as agent for the Lenders.
|
10.36
|
|
Consent to Limited Release of Collateral, dated November 21, 2014, to Second Amended and Restated Term Loan Credit Agreement dated as of December 9, 2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders, and Deutsche Bank Trust Company Americas, as agent for the Lenders.
|
10.37
|
|
Amendment No. 3, dated March 31, 2014, to Second Amended and Restated Credit Agreement dated as of December 9, 2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders, and JP Morgan Chase Bank, N.A., as agent for the Lenders.
|
Exhibit
|
|
Description
|
10.38
|
|
Amendment No. 4, dated November 21, 2014, to Second Amended and Restated Credit Agreement dated as of December 9, 2010, by and among OMNOVA Solutions Inc., as Borrower, the financial institutions party thereto, as Lenders, and JP Morgan Chase Bank, N.A., as agent for the Lenders.
|
|
|
|
12.1
|
|
Computation of Ratio of earnings to fixed charges.
|
|
|
|
|
|
SUBSIDIARIES OF THE REGISTRANT
|
21.1
|
|
Listing of Subsidiaries.
|
|
|
|
|
|
CONSENT OF EXPERTS
|
23.1
|
|
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.
|
|
|
|
|
|
POWER OF ATTORNEY
|
24.1
|
|
Powers of Attorney executed by D. J. D’Antoni, M. J. Merriman, S. W. Percy, L. B. Porcellato, A. R. Rothwell, W. R. Seelbach and R. A. Stefanko, Directors of the Company.
|
|
|
|
|
|
|
|
|
CERTIFICATIONS
|
31.1
|
|
Principal Executive Officer’s Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
31.2
|
|
Principal Executive Officer’s Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
32.1
|
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
101
|
|
The following financial information from our Annual Report on Form 10-K for 2014, filed with the SEC on January 23, 2015, formatted in XBRL: (i) the Consolidated Statements of Operations for the years ended November 30, 2014, 2013, and 2012; (ii) the Consolidated Statements of Comprehensive Income (Loss) for the years ended November 30, 2014, 2013, and 2012; (iii) the Consolidated Balance Sheets at November 30, 2014 and 2013; (iv) the Consolidated Statements of Shareholders’ Equity for the years ended November 30, 2014, 2013, and 2012; (v) the Consolidated Statements of Cash Flows for the years ended November 30, 2014, 2013, and 2012; and (vi) the Notes to the Consolidated Financial Statements.
|
|
|
The Company will supply copies of any of the foregoing exhibits to any shareholder upon receipt of a written request addressed to OMNOVA Solutions Inc., 25435 Harvard Road, Beachwood, Ohio 44122-6201, Attention: Secretary, and payment of $1 per page to help defray the costs of handling, copying and return postage.
|
**
|
|
Incorporated by reference to the same-numbered exhibit to the Company’s Registration Statement on Form 10 (File No. 1-15147).
|
†
|
|
Management contract or compensatory arrangement.
|
|
|
|
|
|
|
|
|
O
MNOVA
Solutions Inc.
|
|
Date:
|
January 23, 2015
|
|
|
|
|
|
|
By
|
/s/ J. C. LeMay
|
|
|
|
|
J. C. LeMay
Senior Vice President,
Corporate Development;
General Counsel
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ K. M. McMullen
|
|
Chairman, Chief Executive Officer and President
|
|
January 23, 2015
|
K. M. McMullen
|
|
|
|
|
|
|
|
|
|
/s/ P. F. DeSantis
|
|
Senior Vice President and Chief Financial Officer
|
|
January 23, 2015
|
P. F. DeSantis
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
January 23, 2015
|
D. J. D’Antoni
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
January 23, 2015
|
M. J. Merriman
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
January 23, 2015
|
S. W. Percy
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
January 23, 2015
|
L. B. Porcellato
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
January 23, 2015
|
A. R. Rothwell
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
January 23, 2015
|
W. R. Seelbach
|
|
|
|
|
|
|
|
|
|
*
|
|
Director
|
|
January 23, 2015
|
R. A. Stefanko
|
|
|
|
|
|
|
|
|
|
*Signed by the undersigned as attorney-in-fact and agent for the Directors indicated.
|
|
|
|
|
|
|
|
|
|
/s/ J. C. LeMay
|
|
|
|
January 23, 2015
|
J. C. LeMay
|
|
|
|
|
|
|
Year Ended November 30,
|
||||||||||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
||||||||||
Pre-tax income (loss) from continuing operations
|
|
$
|
12.1
|
|
|
$
|
26.5
|
|
|
$
|
36.9
|
|
|
$
|
30.1
|
|
|
$
|
33.3
|
|
Adjustment for (income) loss from equity investees
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Pre-tax income (loss) from continuing operations before adjustment for minority interests in consolidated subsidiaries or income or loss from equity investees
|
|
$
|
12.1
|
|
|
$
|
26.5
|
|
|
$
|
36.9
|
|
|
$
|
30.1
|
|
|
$
|
33.3
|
|
Distributed income equity investees
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Less: Capitalized interest
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Amortization of interest previously capitalized
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Adjusted pre-tax income (loss) from continuing operations before adjustment for minority interests in consolidated subsidiaries or income or loss from equity investees
|
|
$
|
12.1
|
|
|
$
|
26.5
|
|
|
$
|
36.9
|
|
|
$
|
30.1
|
|
|
$
|
33.3
|
|
Fixed Charges:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
|
$
|
30.6
|
|
|
$
|
29.6
|
|
|
$
|
33.8
|
|
|
$
|
35.3
|
|
|
$
|
8.0
|
|
Interest capitalized during the period
|
|
1.0
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Amortization of debt issuance costs
|
|
2.3
|
|
|
2.3
|
|
|
2.7
|
|
|
2.7
|
|
|
.7
|
|
|||||
Imputed interest portion of rent expense
|
|
2.3
|
|
|
2.2
|
|
|
1.4
|
|
|
1.4
|
|
|
1.3
|
|
|||||
Total Fixed Charges
|
|
$
|
36.2
|
|
|
$
|
34.1
|
|
|
$
|
37.9
|
|
|
$
|
39.4
|
|
|
$
|
10.0
|
|
Pre-tax income (loss) from continuing operations before adjustment for minority interests in consolidated subsidiaries or income or loss from equity investees plus fixed charges
|
|
$
|
48.3
|
|
|
$
|
60.6
|
|
|
$
|
74.8
|
|
|
$
|
69.5
|
|
|
$
|
43.3
|
|
Ratio of Earnings to Fixed Charges
|
|
1.3
|
|
|
1.8
|
|
|
2.0
|
|
|
1.8
|
|
|
4.3
|
|
|
|
Name of Corporation
|
State of Incorporation or Jurisdiction
|
OMNOVA Performance Chemicals (UK) Ltd.
|
United Kingdom limited company
|
OMNOVA Engineered Surfaces (Thailand) Co., Ltd
|
Thailand limited company
|
OMNOVA Decorative Products (Shanghai) Co., Ltd
|
Chinese wholly foreign owned enterprise
|
OMNOVA Solutions International SAS
|
France
|
OMNOVA Solutions SAS
|
France
|
Eliokem Shanghai Trading Co.
|
Chinese wholly foreign owned enterprise
|
OMNOVA Shanghai Co., Ltd.
|
Chinese wholly foreign owned enterprise
|
OMNOVA Ningbo Co., Ltd.
|
Chinese wholly foreign owned enterprise
|
OMNOVA India Private Limited
|
India
|
(1)
|
The Corporation also controls, directly or indirectly, twenty one other companies that, in the aggregate as a single subsidiary, would not constitute a significant subsidiary, as such term is defined in Rule 1-02 (w) of Regulation S-X.
|
1.
|
Registration Statement No. 333-182524 on Form S-8 pertaining to the OMNOVA Solutions Inc. Third Amended and Restated 1999 Equity and Performance Incentive Plan; and
|
2.
|
Registration Statement No. 333-160509 on Form S-8 pertaining to the OMNOVA Solutions Retirement Savings Plan;
|
1.
|
I have reviewed this Annual Report on Form 10-K of OMNOVA Solutions Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
January 23, 2015
|
/s/ Kevin M. McMullen
|
|
|
Name: Kevin M. McMullen
|
|
|
Title: Chairman, Chief Executive Officer and President
|
1.
|
I have reviewed this Annual Report on Form 10-K of OMNOVA Solutions Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
January 23, 2015
|
/s/ Paul F. DeSantis
|
|
|
Name: Paul F. DeSantis
|
|
|
Title: Senior Vice President and Chief Financial Officer
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
|
Date:
|
January 23, 2015
|
/s/ Kevin M. McMullen
|
||
|
|
Name:
|
|
Kevin M. McMullen
|
|
|
Title:
|
|
Chairman, Chief Executive Officer and President
|
|
|
/s/ Paul F. DeSantis
|
||
|
|
Name:
|
|
Paul F. DeSantis
|
|
|
Title:
|
|
Senior Vice President and Chief Financial Officer
|